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Rapid, sensitive and selective detection of chemical hazards and 
biological pathogens has shown growing importance in the fields of homeland 
security, public safety and personal health. In the past two decades, efforts have 
been focusing on performing point-of-care chemical and biological detections 
using miniaturized biosensors. These sensors convert target molecule binding 
events into measurable electrical signals for quantifying target molecule 
concentration. However, the low receptor density and the use of complex 
surface chemistry in receptors immobilization on transducers are common 
bottlenecks in the current biosensor development, adding to the cost, 
complexity and time. This dissertation presents the development of selective 
macromolecular Tobacco mosaic virus-like particle (TMV VLP) biosensing 
  
receptor, and the microsystem integration of VLPs in microfabricated 
electrochemical biosensors for rapid and performance-enhanced chemical and 
biological sensing. 
Two constructs of VLPs carrying different receptor peptides targeting at 
2,4,6-trinitrotoluene (TNT) explosive or anti-FLAG antibody are successfully 
bioengineered. The VLP-based TNT electrochemical sensor utilizes unique 
diffusion modulation method enabled by biological binding between target 
TNT and receptor VLP. The method avoids the influence from any interfering 
species and environmental background signals, making it extremely suitable for 
directly quantifying the TNT level in a sample. It is also a rapid method that 
does not need any sensor surface functionalization process. For antibody 
sensing, the VLPs carrying both antibody binding peptides and cysteine 
residues are assembled onto the gold electrodes of an impedance microsensor. 
With two-phase immunoassays, the VLP-based impedance sensor is able to 
quantify antibody concentrations down to 9.1 ng/mL. 
A capillary microfluidics and impedance sensor integrated microsystem 
is developed to further accelerate the process of VLP assembly on sensors and 
improve the sensitivity. Open channel capillary micropumps and stop-valves 
facilitate localized and evaporation-assisted VLP assembly on sensor electrodes 
within 6 minutes. The VLP-functionalized impedance sensor is capable of 
label-free sensing of antibodies with the detection limit of 8.8 ng/mL within 5 
minutes after sensor functionalization, demonstrating great potential of VLP-
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Chapter 1: Introduction 
1.1 Motivation and background 
Rapid detection of hazardous chemicals and biological pathogens are 
growing in importance for the applications in security, safety and personal 
health. In security and safety domain, hazardous chemicals, such as explosives, 
have been widely used in both military weapons, and civilian construction and 
mining. In the production, transportation and utilization of these chemicals, 
possible contamination of natural resources and exposure to the public can 
cause environmental and health issues. Also, due to the dangerous nature of 
these chemicals, any mishandling may lead to devastating consequences for 
public safety. Therefore, accurate and rapid monitoring of the presence of such 
chemicals in the environment is crucial. In the public health domain, the 
spreading of contagious diseases caused by viral and bacterial infections have 
escalated due to rapid pathogen mutations and the convenience of global 
transportations [1-3]. In order to contain the spread of diseases at an early stage, 
diagnostic technologies need to be adapted to achieve a reduced response time 
and improved accuracy. In the personal health aspect, medical emergencies 
such as acute myocarditis and acute pancreatitis are life-threatening especially 
when a medical facility is not immediately available. Therefore, a quick 
response, selective and sensitive diagnosis of pathogens or biomarkers is an 
essential step in identifying the source of disease at the early stage and form the 





to develop a universal and rapid-response sensor platform with extraordinary 
versatility to meet these very different needs at different levels. 
During the last two decades, efforts have been focusing on performing 
decentralized (point-of-care) chemical and pathogen detection [4, 5] using 
miniaturized biosensors to achieve fast-response sensing. Biosensors are 
analytical devices that utilize the integration of biological sensing receptors 
with physical sensors. Their transduction mechanism converts biological target 
molecule binding events into measurable electrical signals to quantify target 
molecule concentration[6]. Miniaturized biosensors have been increasingly 
implemented in point-on-care pathogen detection due to their extraordinary 
portability, low cost, versatility and low cost [7, 8]. They have provided fast 
and reliable alternatives to central analytical facilities.   
Selectivity and sensitivity are two essential aspects to characterize the 
performance of a biosensor. To ensure high selectivity, most biosensors utilize 
biological molecules to functionalize the transducers in order to show selective 
affinity to target molecules. Possible biological receptors such as antibodies, 
enzymes, cells, tissues and microorganisms have been integrated in the sensor 
through microfabrication processes [9, 10]. The sensing efficacy is largely 
determined by the density and binding affinity of the immobilized sensing 
receptors, which limit the amount of bound target molecules and control the 
change in signal of the biosensor. Currently, a major challenge associated with 
the most commonly used biomolecule receptors, such as antibodies and DNAs, 





distribution, which often results in low receptor density on transducer surfaces. 
Combining the fact of low surface area of a miniaturized sensor, this may result 
in an impaired sensitivity.  
Recently, the exponential advances in nanotechnology have created new 
possibilities for integration of nanostructured materials (such as gold 
nanoparticles, carbon nanotubes and silicon nanowires) as sensing components 
in biosensors, due to their unique properties such as high surface to volume 
ratios as well as their highly controllable structures. These properties provide 
nanostructured materials the potential for improved signal to noise ratio, 
remarkable selectivity, and the utilization of novel transduction mechanism, 
making them ideal candidates as functional parts in next-generation 
miniaturized sensors as they offer the potential for improved signal to noise 
ratios, remarkable selectivity, and the utilization of novel transduction 
mechanisms. However, the immobilization steps that creating links between 
bioreceptors with nanostructures still require complex surface chemistry to 
create complimentary chemical functional groups on both transducers and 
receptors. The low receptor density and complex surface chemistry in the 
immobilization of receptors on transducers are common bottlenecks in the 
biosensor development, adding to the cost, complexity and time. For these 
reasons, development of new sensing receptors and sensor functionalization 
technologies are necessary for the next generation miniaturized biosensors, 






While significant research has been conducted in the surface 
modification, functionalization and utilization of nanostructured materials in 
microfluidic based sensors, several key challenges still remain. When organic 
nanostructures are used directly as receptor layers, process compatibility and 
the ability to arrange them in a highly ordered fashion in a device is often the 
bottleneck. On the other hand, inorganic nanomaterials are more compatible 
with standard device processing; however, they require special 
functionalization procedures so that they can be conjugated with a probe 
receptor. Besides, while several devices demonstrating binding events between 
nano-probes and analytes have been developed, very little information is 
available on the optimization of nanomaterial integration in immunoassay 
sensors.  
Interestingly, biological structures such as DNA, proteins and viruses 
offers a tremendous library for material synthesis based on their unique 
variations in molecular functionalities and assembly properties. This work 
addresses the aforementioned challenges through the integration of 
nanostructured biological molecule Tobacco mosaic virus-like particles (TMV 
VLPs) as sensing elements in microfabricated devices. Compared to the 
conventional biosensing receptors such as DNA and antibodies, these VLPs are 
much larger macromolecules with well-defined one-dimensional nanostructures. 
Integration of VLPs as sensing receptors can simultaneously solve the 
challenges in both sensitivity and selectivity.  Particular emphasis is placed on 





nanoparticles to identify optimal configurations in the VLP immobilization on 
surfaces. Moreover, a significant amount of effort is focused on the design and 
optimization sensor microsystems in order to facilitate rapid sensor 
functionalization using VLP sensing receptors to meet the needs of sensitive 
on-site and on-demand detection of chemical and biological hazard. 
The detailed research goals of this dissertation are: (1) to develop TMV 
VLPs as versatile sensing elements, (2) to implement VLPs in microsensors for 
selective chemical and biological sensing, (3) to develop a microsystem 
solution for rapid sensor functionalization using VLPs and enhanced biosensing 
performance. This research utilizes experimental investigations to establish the 
optimized sensor functionalization protocol using VLPs. Through the 
integrated sensor microsystem and genetic modification of VLPs, it can be 
expected that VLPs being further explored as versatile and universal sensing 
receptors for rapid chemical and biological detections. 
1.2 Thesis contributions 
The research described in this dissertation constitutes an experimental 
investigation aimed towards the rapid integration of macromolecules - Tobacco 
mosaic virus-like particles (TMV VLPs) – as a highly selective and versatile 
bio-recognition element in microscale biosensors. The VLP-based biosensors 
are suitable for rapid and decentralized analysis of both chemical and biological 
targets. This dissertation contributes to the VLP nanoreceptor integration in 





1.2.1 Accelerated and enhanced VLP receptor assembly process 
The current VLP self-assembly process requires the immersion of the 
entire microdevice in a relatively large volume of VLP solution for around 18 
hours. Despite the long immobilization time and volume, the density of the 
assembled VLP sensing probes (VLP-FLAG) still needs significant 
improvement to achieve better sensitivity for antibody sensing. The time of 
VLP self-assembly process and the density of the assembled VLP layer are 
currently the bottlenecks that limit the sensor preparation and performance.  
This dissertation proposes a new type of evaporation-based VLP 
assembly protocol to solve the aforementioned problems. This process utilizes 
the increased VLP concentration and van der Waals force during the 
evaporation of a droplet of VLP solution to achieve the high VLP density and 
low assembly time. Colorimetric immunoassay demonstrates that the 
biosensing efficacy of VLP remains after the evaporation-based process, and 
the evaporation can improve the localized VLP assembly. Using evaporation-
based VLP assembly process in a capillary microfluidic platform, the density of 
VLP functional layer is significantly improved, resulting in the coverage of 
over 91% on impedance sensor electrodes (vs. ~60% using VLP self-assembly 
process). The assembly time reduced significantly from 18 hours to 6 minutes.  
1.2.2 Integration of VLP receptors in chemical and biological microsensors 
VLP receptors have shown tremendous potentials of being genetically 
engineered to become a universal and versatile vehicle to carry different types 





VLPs have been successfully developed to target the explosive 2,4,6,-
trinitrotoluene (TNT) molecules and anti-FLAG IgG antibodies, respectively. 
These are integrated in both macro- and micro-scale sensor systems.  
For the detection of TNT, VLP receptors are integrated as free-floating 
binding agents that utilize a diffusion modulation-based differential method to 
selectively detect the presence of TNT in solution. This method is the first 
demonstration of utilizing the distinct size difference between sensing probe 
(VLP) and target (TNT) to selectively lower the diffusion coefficient in an 
electrochemical system. This change in the diffusion coefficient generates a 
selective differential current that only related with the biological binding 
between VLP and TNT. The impact of this method is that it significantly 
improved the selectivity of conventional voltammetric sensing without the 
needs for background signal subtractions. The feasibility of using microliters of 
liquid sample to perform TNT trace detection has been validated in a 
microfabricated electrochemical TNT sensor platform.  
To selectively sense the presence of biological analyte, the VLP-FLAG 
receptors are self-assembled on to interdigitated impedimetric microsensor, 
forming a functional VLP receptor layer. Based on the changing complex 
impedance during immunoassay process, the VLP-functionalized impedance 
microsensors are able to selectively detect the biological target in a 
miniaturized platform in real-time. The impedance microsensor is utilized to 
study the VLP self-assembly dynamics on-chip, revealing the gradual 





self-assembled VLP layer is able to detect target antibody at the concentration 
down to 9.1 ng/mL using labelled method – enzyme-linked immunosorbent 
assay (ELISA).  
1.2.3 A microsystem solution for rapid sensor functionalization and label-free 
antibody sensing 
A microsystem platform is developed which utilizes open-channel 
capillary pumps and stop-valves to achieve rapid and localized VLP 
nanoreceptor assembly on an impedance sensor. This is the first demonstration 
of a large-scale open-channel microfluidic system fabricated using bottom-up 
processes. The localization and confinement of VLPs is realized by 
autonomous delivery of the VLP-containing buffer solution on the sensor 
electrode surface and using of the capillary stop valves. The VLP assembly 
process involves evaporation of the VLP solution from micropillar structures in 
the capillary channel. The integrated impedance sensor monitors the assembly 
dynamics of VLP nanoreceptor on the sensor, and performs real-time label-free 
antibody sensing. Sensitivity optimization is also studied by changing the 
receptor VLP concentrations in the sensor functionalization.  
This is the first demonstration of controlled biological nanoreceptor 
immobilization on microsensors through capillary microfluidics. This is also 
the first open-channel capillary microfluidic system that is fabricated using 
bottom-up process using negative photoresist KMPR. It is extremely suitable 
for sensor integration compared to the existing silicon-based capillary 





KMPR sidewalls and more hydrophobic substrate are generated simultaneously, 
creating capillary microfluidics that is controlled by the sidewall geometries. 
The VLP receptors, capillary microfluidics and impedance sensors combined 
also provided a system solution to perform on-demand sensor programing and 
rapid biosensing with minimum user intervention.  
1.3 Literature review 
1.3.1 Biosensor transduction mechanisms 
Biosensors are devices that leverage the highly specific biological 
reactions for sensing of analytes. They combine biological recognition 
elements (specific to the target) with physical transducers that translate bio-
recognition events into a measurable data, such as an electrical signal, an 
optical emission or a mechanical motion [11]. Progress in microfabrication and 
nanomaterials allows development of highly sensitive sensors with the 
additional advantage of miniaturization [12]. Micro- and nano-scale sensors are 
based on microelectronics and the related micro-electromechanical system 
(MEMS) technologies. These sensor components can easily be integrated into 
portable ‘‘lab-on-chip’’ platforms to perform ‘‘point-of-care’’ analysis where 
portability is one of the major requirements. This section provides a review of 
several major biosensors transduction mechanisms and the recent achievements 
in each of the sensor categories.   






Microcantilevers are well-explored and characterized MEMS 
mechanical structures, which are also very promising platforms for micro- and 
nano-scale biosensors. Using highly sensitivity cantilevers as transduction 
platform, the biosensors can achieve local, high resolution and label-free 
molecular recognition measurements [13-15].  
	
Figure 1-1 Principle of differential readout using sensor and reference cantilevers working in 
static mode. [16] (Reprinted with permission from J. Zhang, H. P. Lang, F. Huber, A. Bietsch, W. 
Grange, U. Certa, R. McKendry, H. J. Guntgerodt, M. Hegner, and C. Gerber, Nature 
Nanotechnology, 1,214 (2006). Copyright 2006, Nature Publishing Group) 
The cantilever-based biosensor can be operated in static mode 
(cantilever deflection is measured) or dynamic mode (resonant frequency shift 
is measured). In the static mode, binding between analytes and the immobilized 
recognition molecules on one surface of the cantilever causes a change in 
cantilever surface stress and deflects the cantilever [17]. Figure 1-1 shows the 
schematic of the transduction mechanism of a static-mode cantilever biosensor 





binding adds an additional mass to the oscillating cantilever, decreasing its 
resonance frequency. The static mode can operate well in both gas and liquid 
environments. The dynamic mode works efficiently in gas phase. However, in 
aqueous environments, the viscous damping during the oscillation hinders 
cantilevers working in the dynamic mode [18], which is not desirable. Overall, 
due to its high sensitivity, cantilever-based sensors can achieve label-free 
detection of various targeting molecules, including proteins such as cyanovirin 
[19]， prostate specific antigen [20], antibiotic oxytetracycline [21], and 
pollutants like atrazine [22], trimethylamine [23] and mycotoxin [24]. 
    
 
Figure 1-2 Cantilever biosensors with (a) piezoresistive [25] (reprinted with permission from K. 
W. Wee, G. Y. Kang, J. Park, J. Y. Kang, D. S. Yoon, J. H. Park, and T. S. Kim, Biosensors & 
Bioelectronics, 20, 1932 (2005). Copyright 2005, Elsevier) and optical [26] readout setups. 
(reprinted with permission from C. M. Dominguez, P. M. Kosaka, A. Sotillo, J. Mingorance, J. 
Tamayo, and M. Calleja, Analytical Chemistry, 87, 1494 (2015). Copyright 2015, American 
Chemical Society)  
Piezoresistive and optical methods are two major readout mechanisms 
for cantilever biosensors.  The core of the piezoresistive readout method is a 
half Wheatstone bridge placed on cantilevers. Due to the bending of cantilevers 
from the biological binding event, one of the resistors in the circuit changes its 






measured and related to the target concentration. The other readout method is 
optical-based, which utilizes the change in a reflected laser beam to quantify 
the amount of cantilever bending. This method usually relies on an external 
point laser to shine on the tip of the cantilever sensor in order to generate the 
reflection light beam. When the biological binding changes the bending of the 
cantilever, the reflected laser beam changes the location on a position sensitive 
optical detector that can be related with the target molecule concentrations.  
Electro-acoustic biosensor (piezoelectric biosensor) 
 
Figure 1-3 The electrode configuration of the Maxtek quartz crystal microbalance (QCM) chip 
[27]. (Reprinted with permission from M. Rodahl, F. Hook, and B. Kasemo, Analytical 
Chemistry, 68, 2219 (1996). Copyright 1996, American Chemical Society.) 
The other major sub-category of mechanical biosensor is electro-
acoustic sensors. These sensors utilize piezoelectric effect to generate 





(QCM) is one of the most established electro-acoustic sensors. QCMs are 
centimetre-scale mechanical resonators based on the property of an AT cut 
quartz crystal which oscillate when alternating voltage are applied. QCM 
sensors can measure the inertial mass of analytes attaching on their surfaces in 
vacuum, gas or fluid [28, 29]. A decrease in the resonant frequency occurs with 
molecules attachments, which can be measured in real time. When analysing a 
liquid-phase analyte, half of the crystal is exposed to the liquid in a flow-cell as 
shown in Figure 1-3. Fluid-based QCM biosensing capability spans the nano- 
to femtomolar range: nanomolar detection limit is reported for continuous 
analyte monitoring using an indirect-competitive assay [30], and 85 fM 
detection limit has been reported for end-point detection sandwich assays 
involving device removal from fluid, drying, and subsequent measurement in 






Figure 1-4 (a) Schematic cross section view of the shear mode thin film bulk acoustic resonator 
(FBAR) biosensor with an integrated fluidic channel beneath the active area [32]. (Reprinted 
with permission from G. Wingqvist, Surface & Coatings Technology, 205, 1279 (2010). 
Copyright 2010, Elsevier)(b) Basic SAW biosensor setup exemplified by a SAW immunosensor 
[33]. (Reprinted with permission from K. Lange, B. E. Rapp, and M. Rapp, "Surface acoustic 
wave biosensors: a review," Analytical and Bioanalytical Chemistry, vol. 391, pp. 1509-1519, Jul 
2008.Springer) 
Different from the QCM that is based on single crystalline bulk material 
oscillation, other piezoelectric resonator-based biosensors developed recently, 
including thin film bulk acoustic resonator (FBAR) and surface acoustic wave 
resonator (SAW), use thin films of polycrystalline materials deposited with IC-
compactible process. These sensors operate based on piezoelectric effect, and 







resulting in higher sensitivity compared to QCM. The advantages of the FBAR 
devices include: (1) the ability to fabricate the device using standard CMOS 
processing and materials allowing integration with CMOS control circuitry; (2) 
the size and volume can be significantly reduced [34]. The SAW sensors 
working in Love mode, where surface acoustic wave is much confined in the 
piezoelectric layer, are quite suitable for biosensing in liquid samples [33, 35]. 
1.3.1.2 Optical biosensors 
In the past two decade, optical sensor development has been a fast-paced 
area because they are immune to electromagnetic interference, capable of 
performing remote sensing, and can provide multiplexed detection within a 
single device [36]. Two most popular optical biosensor formats are based on 
surface plasmon resonance (SPR) and optical fibers and Whispering-gallery-
mode (WGM) recirculation. They are extremely sensitive devices with the low 
detection limit down to fM range. However, there is still challenges in the 
integration in a lab-on-a-chip platform and compatibility with the IC 






Figure 1-5 Formation of surface plasmon resonance wave for sensor. [37] (Reprinted with 
permission from M. Piliarik, H. Vaisocherová, and J. Homola, Biosensors and Biodetection, 65 
(2009). Copyright 2009, Springer) 
The SPR-based biosensor is based on total reflection of a laser beam in a 
glass prism attached on the backside of a thin (thickness smaller than 50nm) 
metal film. A light wave excites surface plasmon propagating along the on the 
metal/media interface [37]. The angle of incidence at which surface plasmon 
occurs is called the SPR angle and is determined by the angular frequency of 
the light source, dielectric constant of the metal and the geometry of the prism. 
However, if these are not changed, then the SPR angle depends only on the 
refractive index (n) of the ambient medium, on the far side of the gold film. 
Therefore, if an analyte is passed over an immobilized bioreceptor on the far 
side of the gold surface, a change in the SPR angle is produced.  
	
 
Figure 1-6 Concept of the WGM biosensor [38]. (Reprinted with permission from F. Vollmer and 





The biosensing concept using a WGM biosensor is illustrated in Figure 
6. First of all, the resonant wavelength/frequency and the shift in the 
wavelength/frequency can be identified through the transmission spectrum 
(Figure 6a); WGM in a dielectric sphere is driven by the evanescent coupling 
though the optical fiber (Figure 6b); when biomolecules bind on the receptor 
immobilized sphere, the refractive index changes on the sphere which causes 
resonant wavelength/frequency shift (Figure 6c). [38]  
1.3.1.3 Electrical biosensor: 
Electrical biosensors include biomolecule-functionalized filed effect 
transistors, voltammetric, amperometric and impedimetric electrochemical 
sensors. They rely solely on the measurement of currents and/or voltages to 
detect target binding [39-42]. Compared with other biosensors operating using 
optical, mechanical or magnetic principles, electrical biosensors do not require 
special excitations other than applied electrical potential or current. Electrical 
sensors are also independent from intermediate transduction mechanism such 
as transferring the biological binding events into mechanical displacements or 
light reflection angle changes. Thus, electrical biosensors can be fully 
integrated with integrated circuits, and are promising devices for point-of-care 
diagnostics and on-site analysis due to their low cost, low power and ease of 
miniaturization.  
Amperometric and voltammetric electrochemical biosensors always 
utilize the electrochemical characteristics of the target analyte or the 





quantify the target concentrations. Glucose biosensors are of the well-
investigated electrochemical biosensors that operate in amperometry mode. 
Amperometric enzyme electrodes, based on glucose oxidase (GOx), have 
played a leading role in glucose monitoring in blood. The enzyme electrodes 
concept was first proposed back in 1962, where the glucose level can be 
measured by the oxygen consumption through the enzyme-catalyzed reaction 
[43]. The recent development of amperometric glucose biosensors is more 
focused on performing reagentless glucose without the need for mediator. In 
these sensors, the electron is transferred directly from glucose to the electrode 
via the active site of the enzyme [44-46]. Figure 4 summarizes various 
generations of amperometric glucose biosensors based on different mechanisms 
of electron transfer, including the use of natural secondary substrates, artificial 
redox mediators, or direct electron transfer. 
	
Figure 1-7 Three generations of amperometric enzyme electrodes for glucose based on the use of 
natural oxygen cofactor (A), artificial redox mediators (B), or direct electron transfer between 
GOx and the electrode (C). [44] (Reprinted with permission from J. Wang, Chemical Reviews, 





Voltammetry is another versatile technique in electrochemical analysis, 
where redox current of electroactive species is recorded with the applied 
potential. The position of peak current is related to the specific analyte, and the 
peak current amplitude is proportional to the concentration of the 
corresponding species. Voltammetry is able to detect multiple compounds, 
which have different peak potentials, in a single electrochemical experiment (or 
scan), thus offering the simultaneous detection of multiple analytes [9]. 
Voltammetry has been widely used for detecting a wide range of chemical and 
biological targets such as TNT explosive [47], dopamine [48], carcinogen 
Sudan II [49], caffeine [50], etc.  
Impedimetric biosensors measure the electrical impedance of an 
interface in AC steady state with constant DC bias conditions [39]. The method 
is usually referred to as electrochemical impedance spectroscopy (EIS), and 
usually requires imposing a small sinusoidal potential at different frequency 
and measuring the current between the electrodes. By combining the phase 
information, the voltage-current ratio provides complex electrical impedance. 
EIS has been used to study a variety of electrochemical phenomena over a wide 
frequency range [51-54]. EIS can be used to detect target binding on the 
electrode surface (which usually has receptor probes immobilized on the 
surface in advance) by monitoring the impedance of the electrode-solution 
interface changes.  
Impedance biosensors can detect a variety of target analytes by simply 





as bacteria, the changing in solution resistance Rs and dielectric capacitance 
between the microfabricated electrodes becomes more important.  
	
Figure 1-8 (a) The equivalent circuit for the label-free impedance measurement system coupled 
with magnetic nanoparticle-antibody conjugates  for the detection of E. Coli O157:H7, (b) Bode 
diagrams of the impedance spectra of experimental and curve fitted data in a rang range of 
frequency from 10 Hz to 1 MHz [52]. (Reprinted with permission from M. Varshney, Y. B. Li, B. 
Srinivasan, and S. Tung, Sensors and Actuators B-Chemical, 128, 99 (2007). Copyright 2007, 
Elsevier) 
From the bode diagrams of the impedance spectra in Figure 1-8b, at a 
relative low frequency, double layer capacitance in an impedance biosensors is 
the most dominant component which is more sensitive to surface binding. In 
general, impedance biosensors have potential for simple, rapid, label-free, low-






Figure 1-9 Carbon nanotube (CNT)-based transistor for biosensing of glucose.[55] (Reprinted 
with permission from K. Besteman, J. O. Lee, F. G. M. Wiertz, H. A. Heering, and C. Dekker, 
Nano Letters, 3, 727, (2003). Copyright 2003, American Chemical Society) 
Another kind of electrical biosensors operates by field-effect modulation 
of carriers in a semiconductor due to nearby charged particles [56]. These field-
effect sensors rely on the interaction of external charges with carriers in a 
nearby semiconductor and thus exhibit enhanced sensitivity at low ionic 
strength where counter-ion shielding effect is reduced [39]. Figure 1-9 
demonstrates GOx-coated semiconducting SWNTs act as sensitive pH sensors 
and that the conductance of GOx-coated semiconducting SWNTs changes upon 






1.3.1.4 Summary of biosensor transduction mechanism 
Table 1 summarizes the state-of-the-art biosensors working under 
different sensing mechanisms.  








Target Detection limit Reference 






















Yes antibody antigen (PSA) 100 pM [58] 
Dynamic 









No antibody antigen (PSA) 1.5 fM [60] 
Dynamic 
mode in air Yes 
Phosphoric 
acid / gelatin TNT 70 pg [61] 
QCM, FBAR 
or SAW 







No ssDNA DNA 1fM [62] 




Virus (HPV)  
50nM [63] 
FBAR, shear 





mode Yes antibody 
antigen 
(carbaryl) 3.2 ppb [65] 
SAW Yes antibody antigen (Ebola virus) 
1.9 × 104 
PFU/mL [66] 
Optical:       
SPR 

















No antibody  antigen  6.5 pM [70] 
Electrical:       
Amperometric 
sensor 





Yes glucose oxidase  glucose 23 µM [46] 
Graphene 
electrode Yes silk peptide 
Bisphenol A 




Yes lactate oxidase 
hydrogen 

























Yes Titanate nanotubes Dopamine 0.1 µM [48] 
Impedimetric 
sensor 
Faradaic Yes  Aptamer Lipopolysaccharide 1 pg/mL [75] 
Faradaic Yes Aptamer 
E. Coli outer 
membrane 
proteins 
0.1 µM [76] 
Faradaic Yes Aptamer  17β-estradiol 2 pM [77] 




1 pfu/mL [78] 
Faradaic Yes ssDNA ssDNA 4 nM [79] 
Non-Faradaic Yes ssDNA ssDNA 100 nM [80] 




FET Yes Antibody 
Antigen 
(PSA) 5 pM [82] 
Si nanoribbon No Antibody antigen 0.6 pM [83] 
 
Comparing all the transducers, electrochemical transducers are generally 





biological molecules. They are also more compatible with integrated circuitry 
and electronic components because of the requirements for direct electrical 
excitations and measurements. Because electrochemical sensor electrodes can 
be on the microscale to millimetre-scale, the sensors are relatively easy to be 
integrated with microfluidic platform for lab-on-chip applications.  
1.3.2 Lab-on-a-chip (LOC) – sensor and microfluidics integration 
The appealing feature of an LOC device is that it can perform laboratory 
operations on a small scale using miniaturized platforms. Small volumes reduce 
the time required to synthesize and analyze a product; the unique behavior of 
liquids at the microscale allows greater control of molecular concentrations and 
interactions; and reagent costs and the amount of chemical waste can be greatly 
reduced [84]. Compact LOC sensors also enable the analysis of samples at the 
point of need rather than in a centralized laboratory facility. Due to the 
favorable features of low volume, fast response, multiplexed operation and 
precise control, there has been an exponential increase in the LOC 
implementations in research fields such as gene expression analysis[85-87], 
cell manipulation and separation (Figure 1-10a) [88, 89], drug development[90, 







Figure 1-10(a) SEM micrographs of pillar-type barrier for blood cell separation[89] (Reprinted 
with permission from X. Chen, D. F. Cui, C. C. Liu, and H. Li, Sensors and Actuators B: 
Chemical, 130, 216,(2008). Copyright 2008, Elsevier) (b) Concept of a capillary-driven 
microfluidic chip for effecting immunoassays with one step[97]. (Reprinted with permission from 
L. Gervais and E. Delamarche, Lab on a Chip, 9, 3330, (2009). Copyright 2009, Royal Society of 
Chemistry) 
In the sensing domain, LOC sensors are mainly aimed at achieving 
multiplexed sensor arrays on chip for drug discovery and portable sensing 
platform for point-of-care clinical diagnostics or in field bio-/chemical 
detections. A great diversity of transducers has been integrated with 
microfluidics to create LOC biosensor systems. The transduction mechanisms 
of these sensors are based on optical (optical density, surface plasmon [98] 
(Figure 1-11a) or Raman spectroscopy), electrical/electrochemical 
(amperometric, potentiometric, impedimetric or field effect transistor [99] 
(Figure 1-11b)), paramagnetic particle or mass loading (cantilever or acoustic) 
(Figure 1-11c, d) [33, 51, 57, 100-102]. These transducers need to be 
programed with functional receptors in order to selectively detect a specific 
target molecule or biomarker with immunoassays.  
In a LOC system, microfluidics is the enabling technology to deliver and 
control the low volume of samples in the device. A microfluidic platform 
provides a set of fluidic unit operations that can be combined with 
microfabrication technology. The platform allows the implementation of 
different application specific systems (assays) in an easy and flexible way, 
based on the same fabrication technology [103]. Microfluidic systems are part 





samples and reagents) on a small scale. They are fast, compact and can be 
made into a highly integrated system to deliver purified samples, perform 
separation, reaction, immobilization, labelling, as well as detection, and thus 
are promising for applications such as LOC and handheld healthcare devices 
[104]. 
  
               
Figure 1-11(a) diagram of surface plasmon resonance sensor operation [98] (Reprinted with 
permission from A. Duval, F. Bardin, A. Aide, A. Bellemain, J. Moreau, and M. Canva, 
Copyright 2007, SPIE.org), (b) portable amperometric sensor [99] (K. S. Kim, H.-S. Lee, J.-A. 
Yang, M.-H. Jo, and S. K. Hahn, Nanotechnology, 20, 235501, (2009). Copyright 2009, IOP 
PUBLISHING, LTD), (c) microcantilever biosensors  [57, 101] (N. Backmann, C. Zahnd, F. 
Huber, A. Bietsch, A. Pluckthun, H. P. Lang, H. J. Guntherodt, M. Hegner, and C. Gerber, 
PNAS, 102, 14587,(2005). Copyright 2005, National Academy of Sciences, USA ) (Reprinted with 
permission from J. H. Lee, K. H. Yoon, K. S. Hwang, J. Park, S. Ahn, and T. S. Kim,  Biosensors 
& Bioelectronics, 20, 269,(2004). Copyright 2004, Elsevier) and (d) surface acoustic wave sensors 
[102] (Reprinted with permission from M. I. Rocha-Gaso, C. March-Iborra, A. Montoya-Baides, 
and A. Arnau-Vives,  Sensors, 9, 5740, (2009). Copyright 2009, MDPI) 
Among the various applications that can be implemented in 








due to their significance in identifying infections and diseases [105-108]. This 
can be accomplished by screening for specific proteins, antibodies, or other 
biomarkers or through DNA separation and hybridization.  Some characteristic 
examples include enzyme-linked immunosorbent assays (ELISAs), where 
antigen-antibody binding is detected by measuring the activity of an enzyme 
linked to a secondary antibody that is attached to the complex, and DNA 
hybridization, where the presence of a specific nucleic acid sequence is 
screened through attachment of the chain of interest to its complementary. The 
traditional bench-top processes are slow, consume large amounts of reagents, 
and cannot be easily automated. Consequently, efforts have been directed 
towards their miniaturization and in fact, multiple reports have been published 
on both LOC ELISA [109-115] and DNA analysis [116-121].  
1.3.3 Nanostructured materials in microsensors 
In addition to sensor and auxiliary component miniaturization, the 
overall performance of the down-scaled device can be improved through the 
use of nanostructured materials as binding agents. Indeed, nanostructures can 
offer significant benefits such as higher sensitivity, lower detection potentials, 
larger dynamic range, improved signal to noise ratios, and higher separation 
efficiencies [122, 123]. They can be used in suspended and stationary phases to 
facilitate electrophoretic or chromatographic separations as well as to directly 





1.3.3.1 Nanoparticle Sensors 
Various nanoparticles have been reported as detectors and separators in 
microfluidic sensors, including gold, silica, magnetic nanoparticles, and 
quantum dots. Composites of NiFe2O4 and SiO2 were combined with 
electrochemical sensing for tumor marker screening, where the magnetic core 
allowed manipulation of the receptors in the microchannel and the silica cell 
facilitated functionalization with the specific antigen [124]. Similarly, 
core/shell/shell nanoparticles of Fe3O4/chitosan/Au have also been reported 
[125]. Chitosan promoted gold attachment which in turn bound to the probe 
proteins. Gold and silica nanoparticles have been used to improve 
electrophoretic separation efficiency by coating the sidewalls of microfluidic 
channels [116, 126, 127], or, in the case of gold, as SERS-active particles in 
microfluidic devices [128].  The unique size-tunable fluorescent quantum dots 
have also been employed. Hu et al. used DNA fragments and 
biotin/streptavidin conjugation chemistry to attach probe molecules onto 
CdTe/CdS nanoparticles [129], while Zheng et al. trapped quantum dots on 
microbeads in fluidic chambers using multi-depth microfluidics [130].  
Notwithstanding the benefits of this approach, their utilization in low-cost 
autonomous LOC is hindered by the integration incompatibilities (they require 
magnetic, electrical, or chemical forces to be used in a device) as well as the 
need for post-integration biofunctionalization.  
1.3.3.2 1-D and 2-D Nanosensors  
Nanowires, nanotubes and 2-D materials such as graphene can 





be patterned selectively in microfabricated sensors. This facile integration has 
enabled their use in microfluidics for both chemical and biological sensing. Ni 
nanowires [131] and carbon nanotubes [132] have been used to improve the 
detection efficiency of electrophoretic separations due to their catalytic 
properties, while silicon nanowires have served as high-surface-area pre-
concentrators as well as sensitive field effect transistors (Figure 1-12a), where 
the conductivity of the nanowire is modulated by the charge of the bound 
molecule in a “bio-gating” effect [133-137]. Similar to the nanoparticles 
however, receptor functionalization of the nanowires is a tedious process that 
often requires up to three different steps of surface modification reactions to 
attach the molecule on the surface [137]; they also have to be used in buffer 
solutions with controlled conductivity. In other examples, the unique 
conductivity properties of graphene as well as the presence of aromatic rings 
that promote the attachment of proteins have also allowed it to be used as a 
transducer in microfluidics [138] (Figure 1-12b). In more sophisticated 
approaches, graphene has been modified with selective binding peptides that 
can bind both to the substrate and the analyte [139]. Most implementations 
have been focused on vapor-based disease biomarker and explosive detection 
sensors [139, 140]. While peptides enable a simplified device functionalization 







Figure 1-12 (a) Si Nanowire-based microfluidic device consisting of vertically attached arrays as 
protein pre-concentrators and Si-nanowire FETs where the proteins can then be sensed [133], 
(Reprinted with permission from V. Krivitsky, L. C. Hsiung, A. Lichtenstein, B. Brudnik, R. 
Kantaev, R. Elnathan, A. Pevzner, A. Khatchtourints, and F. Patolsky, Nano Letters, 12, 4748, 
(2012). Copyright 2012, American Chemical Society) (b) microfluidic malaria cell sensor with 
device patterned chemically functionalized graphene [138]. (Reprinted with permission from P. 
K. Ang, A. Li, M. Jaiswal, Y. Wang, H. W. Hou, J. T. L. Thong, C. T. Lim, and K. P. Loh, Nano 
Letters, 11, 5240, (2011). Copyright 2011, American Chemical Society) 
1.3.3.3 Nanosensors Based on Virus Scaffolds 
Filamentous viruses are simple, well-structured macromolecular 
assemblies of coat proteins that form rod or tube-shaped particles. These 
nanostructures can be ideal bio-recognition elements in sensor applications due 
to their high-aspect-ratio and genetic modification potential that enable 
expression of binding sites with very high density. The Tobacco mosaic virus 
(TMV) is a well-studied plant virus that consists of a single stranded RNA 
coated with 2,130 identical copies of coat proteins. Each of its physiological 
components (CP and RNA strain) has been used as a binding receptor. Previous 
work by our team has shown that TMV can facilitate DNA hybridization onto 
chitosan functionalized gold electrodes [141]. Chitosan was electrodeposited on 
the gold electrode and acted as an immobilization site for probe DNA; this was 
then linked with a complementary DNA attached to the viral RNA, exposed 





1-13a). This process has been used by others to sense differentially labeled 
nano-templates as well as barcode-type biomolecules [142, 143]. The chemical 
modification capabilities of the virus coat proteins have also been reported, 
mostly in chemical sensors applications. For example, oligoaniline-modified 
and cysteine-modified TMV that promotes metallic particle nucleation have 
been explored as sensors for volatile organic compounds and hydrogen, 
respectively [144, 145]. 
 
Figure 1-13 (a) DNA hybridization using partially disassembled TMV [141], (American 
Chemical Society) (b) M13 assembled on a quartz crystal microbalance for positive antibody 
immunoassays [146], (Reprinted with permission from L. M. C. Yang, J. E. Diaz, T. M. McIntire, 
G. A. Weiss, and R. M. Penner,  Analytical Chemistry, 80, 933, (2008). Copyright 2008, 
American Chemical Society) (c) M13 assembled on gold-coated microbeads to mimic cellular 
structure for enhanced detection efficiency [147]. (Reprinted with permission from C. S. Jeon, I. 
Hwang, and T. D. Chung, Advanced Functional Materials, 23, 1484, (2013). Copyright 2013, 
Wiley) 
M13 bacteriophage is another filamentous virus that can replicate in 
bacteria. It consists of 2,700 copies of major coat proteins and 5 minor coat 
proteins surrounding a DNA genome.  Similar to the TMV, it can be 





antibodies on the coat proteins has enabled immunoassays with the M13, using 
quartz crystal microbalances (QCMs) as mass sensors (Figure 1-13b) [146], as 
well as Poly(3,4-ethylenedioxythiophene) (PEDOT) nanowires in microfluidic 
impedance sensors [148]. Binding efficiency can be increased by immobilizing 
M13 onto Au coated microspheres to form hierarchical surfaces resembling 
biological cellular structures and thus enhance ligand-receptor interactions 
(Figure 1-13c) [147]. The detection method can be simplified by incorporating 
thiolated coat proteins that capture gold nanoparticles and induce color changes 
associated with plasmon shifts [149]. More complex coat protein modifications 
have also been achieved to selectively target trinitrotoluene (TNT) molecules 
[150] and express ssDNA probes [151, 152] via a combination of genetic 
mutation and chemical conjugation.  
These demonstrations indicate that viruses can be unique functional 
nanostructured building blocks in highly sensitive and selective platforms; 
however, most have been implemented in macro-scale experimental settings. 
Very little information is available on their integration in microfluidic devices 
as well as their behavior and stability under flow conditions. This could be a 
problem particularly with bacteriophages, which are longer, thinner, and less 
robust compared to the rigid rod Tobacco mosaic virus. This latter property that 
enables 3-D self-assembly makes the TMV an excellent candidate for efficient 





1.4 Structure of dissertation 
Chapter 1 has presented the motivation for this research and the relevant 
work found in literature. Chapter 2 discusses the VLP receptor genetic 
modification, purification process, self-assembly morphology and validation of 
biosensing functionality using colorimetric methods. Chapter 3 discusses the 
integration of VLPs as receptors in microsensors for chemical explosive 
sensing. Chapter 4 studies the integration of VLPs in impedance microsensor 
for antibody sensing. Chapter 5 is focused on the design, fabrication and 
characterization of a sensor microsystem for rapid and enhanced VLP assembly 
and biosensing. Chapter 6 summarizes the contributions of this dissertation and 










Chapter 2: Tobacco mosaic virus-like particles as sensing 
receptors 
This chapter discusses the genetic modification and purification methods 
of Tobacco mosaic virus-like particle (VLP) sensing receptors, surface 
morphology and biosensing efficacy of VLPs assembled through evaporation-
based method on-chip. 
Professor James N. Culver and Mr. Adam D. Brown contributed to 
developing the methods and protocols for genetically modifying E. coli 
bacterial cells to produce TMV coat proteins with self-assembly capabilities. 
Professor James N. Culver, Mr. Adam D. Brown, Ms. Lindsay Naves and Dr. 
Xiao Zhu Fan contributed to the purification of VLPs from bacterial cells. 
2.1 Tobacco mosaic virus (TMV) 
The Tobacco mosaic virus (TMV) is a highly infectious filamentous 
plant virus with a rigid high-surface-area nanorod structure. It is formed by 
2,130 identical coat protein (CP) subunits stacked in a helix around a single 
strand of RNA. The length of TMV is about 300 nm controlled by the 
encapsulated genomic RNA, and the outer diameter of the nanorod structure is 
about 18 nm. The helical protein arrangement and the nanorod structure of 
TMV are shown in Figure 2-1. The molecular weight of each coat protein is 
17.5 kDa; they self-assemble into a helical structure with 16 ⅓ coat proteins per 
turn around the RNA. Each CP of a wild type TMV is composed of a folded 
chain of 158 amino acids. Both N and C termini of the CP amino acid chain are 





genetically engineered to show functional affinity to certain materials or target 
molecules by the expression of additional amino acid sequences on the N or C 
terminus of the CP.  
 
Figure 2-1(a) Diagram showing the structural composition of a TMV and one of its coat proteins. 
The top and side perspectives of the virus model show a helical tube viral structure. [153] 
(Reprint with permission from X. Z. Fan, E. Pomerantseva, M. Gnerlich, A. Brown, K. 
Gerasopoulos, M. McCarthy, J. Culver, and R. Ghodssi, Journal of Vacuum Science & 
Technology A, 31, (2013). Copyright 2013, AIP Publishing LLC.) (b) An AFM image showing 
TMV nanorod structure. 
The typical preparation of TMV includes tobacco plant culture, infection 
and virus extraction, which take around one month. Also, from the 
experimental experience, the efficacy of plant infection and the final yield of 
TMV are closely related with the genetic modification on its RNA. To 
overcome the limitations in TMV preparation, research has focused on a 
different route to develop TMV virus-like particles (VLPs) that retain the TMV 
CP nanostructures and genetically programmable receptors, but feature shorten 






2.2 Virus-like particles – genetic modifications 
The virus-like particles (VLPs) are direct derivatives of the natural TMV. 
In order to achieve faster preparation with higher yield compared to TMV, the 
VLP culture uses bacterial cells as hosts other than plants. To achieve nanorod 
structures with receptors as TMVs from a bacterial cell host, several genetic 
modifications on the CP sequence are necessary.  
2.2.1 Genetic modifications for stable coat protein assembly into nanorod 
The VLP nanorod structure is self-assembled on the molecular level 
from TMV CPs inside E. coli cell. In order to achieve the similar nanorod 
structure as the TMV, special genetic modifications on the CPs are necessary to 
initiate the molecular level CP self-assembly and bind the individual CPs 
together.  
In nature, the repulsive carboxylate groups located on opposite sides of 
CP subunits govern the stability of the TMV nanostructure. The negatively 
charged carboxylates are stabilized by protons and the Ca2+ ions that regulate 
the stability of the interrelationship between coat protein subunits to form a 
helical structure. The third axial carboxylate interaction that significantly drives 
the particle assembly occurs between the residues E50 and D77. The mutations 
of E50Q and D77N have been shown to block virus disassembly even in the 
absence of the nucleic acid backbone [154].  
Therefore, both E50Q and D77N modifications have been engineered in 





bacterial cells. These genetic modifications have realized a VLP structure 
consisting of self-assembled TMV CPs but without the viral nucleic backbone.  
2.2.2 Genetic modifications for surface attachment and target binding 
As is introduced in 2.1, the N- and C-terminus of each CP is exposed on 
the outer side of the TMV (and thus also VLP) nanorods, providing 
biologically programmable affinity through the alternation of the amino acid 
sequence at the terminus. In microsensors for chemical or biological analysis, it 
is desired to integrate a selective functional surface layer of receptors with 
transducers to sense the presence of target molecules. Therefore, the VLP 
genetic modifications toward sensing applications are aimed at (1) promoting 
the attachment of VLPs on transducer surfaces and (2) providing highly 
specific binding affinity to the target molecules.  
To address (1), the CP N-terminus has been genetically engineered to 
express a cysteine residue. Cysteine (C) is an α-amino acid with a thiol side 
chain that often participates in enzymatic reactions. Gold is a widely used 
electrode material for electrical transduction-based sensors. Since gold reacts to 
form a strong bond with both with reduced alkanethiols (-SH groups) and 
alkyldisulfides(-S-S-) [155], thiol-containing cysteine residue can be used as 
terminal thiol residue to enable the self-assembly of VLPs directly onto a gold 
surface.  
As for the second aim, functional peptides have been expressed on the 
CP C-terminus aimed at conferring VLP specific affinity to target molecules., 





FLAG-tag sequences (VLP-FLAG) – have been successfully expressed as 
model systems to study the feasibility of using VLPs as receptors in chemical 
sensor or biosensor. The TNT binding peptide contains 12 amino acids 
(WHWQRPLMPVSI) which shows high affinity for the target 2,4,6-
trinitrotoluene (TNT) molecules even over other similar nitro aromatic 
compounds such as 2,4-dinitrotoluene (DNT) [156]. In VLP-FLAG (Figure 
2-2), CPs are genetically modified to expressed the 8 amino acid FLAG-tag 
(DYKDDDDK) – a widely used labelling sequence that selectively binds with 
anti-FLAG antibody. These two variants of VLPs are used as biorecognition 
elements to selectively sense the biological or chemical targets. 
 
Figure 2-2 Diagrams of genetically modified VLP-FLAG sensing probes. [157] (Reprinted with 
permission from F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, 
Biosensors and Bioelectronics, 81, 401, (2016). Copyright 2016, Elsevier) 
2.3 VLP culture and purification procedure 
The first step in the preparation of the VLP is to inoculate the E. Coli 





molecule that contains the code to produce the peptide modified CP sequence). 
A small stock sample of bacteria is placed in a test tube containing 5 mL of 
Lysogeny broth (LB) media supplemented with antibiotics to ensure only 
desired bacterial cells survive – 100 µg/mL of ampicillin, 50 µg/mL of 
chloramphenicol (for production of VLP-FLAG) or 20 µg/mL of nalidixicacid 
(for production of VLP-TNT) (Figure 2-3). The bacteria samples were 
cultivated in a 37 oC shaker/incubator overnight. The volume of the bacterial 
culture was then scaled the volume up to 50 mL on the next day by adding the 
original 5 mL bacteria samples into 50 mL LB media with the sample ratio of 
antibiotics described previously. The culturing process continued until the 
optical density reading of the bacteria growth solution at λ = 600 nm reached 
OD600 = 0.5.  
  
Figure 2-3 Schematic of the culturing process of E. coli bacteria from freezer stocks for 
producing VLP-TNT. 
Once an OD reading of 0.5 was reached, the bacteria were induced to 
form TMV coat proteins by transcribing pre-programmed vectors. This was 





thiogalactopyranoside (IPTG), and leaving the solution overnight on a shaker at 
25oC. During this process, CPs form and simultaneously self-assemble into 
helical nanorods in the bacterial cells due to the genetic modifications 
discussed in 2.2.1. 
 
Figure 2-4 Transmission electron microscopy images of (left) E. coli bacterial cells with VLPs 
growing inside. The CPs assembled themselves into nanorod structures and closely packed in 
bacteria (right) [154]. (Reprinted with permission from A. D. Brown, L. Naves, X. Wang, R. 
Ghodssi, and J. N. Culver, Biomacromolecules, 14, 3123 (2013). Copyright 2013, American 
Chemical Society) 
Figure 2-4 shows the E. coli bacterial cells containing VLP nanorod 
structures after induction. To extract the VLP from the bacterial cells, the 
solution was centrifuged at 10 thousands revolutions per minute (krpm) at 4oC 
for 10 minutes. The supernatant was discarded and the pellet containing the 
bacterial cells was re-suspended in 2.5 mL of Bug Buster Protein Extraction 
Reagent and 1 µL of Lysonase Bioprocessing Reagent. The re-suspending 
process was performed on a rotisserie for 45 minutes at room temperature to 






then added in solution and mixed for another 10 minutes to break the disulfide 
bond between the adjacent VLP rods. The solution was then transferred into 
microcentrifuge tubes and spun at 3 krpm for 1 minute in order to separate the 
VLPs from high density residues. The supernatant containing the VLPs was 
transferred into ultracentrifuge tubes and diluted in 0.1M phosphate buffer. 
Ultracentrifugation was then performed at 30 krpm for 30 minutes to collect the 
VLPs in the pellet. The purity of the VLP sample after re-suspension was 
assessed using protein gel electrophoresis (Figure 2-5). The lowest bands in 
Figure 4-3 represent TMV CPs. Comparing the density of these bands, it can be 
concluded that the VLP-FLAG has higher yield than VLP-TNT. This may be 
caused by the attachment of CPs in VLP-TNT samples to the pelleted high-
density residues during the low-speed centrifugation due to the hydrophobicity 
of the TNT peptides. 
  
Figure 2-5 Protein gel electrophoresis of the VLP samples after centrifugations. Both VLP-TNT 
and VLP-FLAG samples showed clear and dense coat protein bands (lowest on each column) 






For VLP-FLAG samples, further purification steps were taken by first 
re-suspending the pellet and loading it onto a sucrose gradient solution with the 
total sucrose of 25%, which was followed by centrifugation at 22.5 krpm for 20 
minutes to separate VLPs from residues with similar density. A bright section 
that contained VLPs in the sucrose gradient solution was observed under 
illumination. This section of the sucrose gradient solution was extracted and 
centrifuged in 0.1M sodium phosphate buffer at 30 krpm for 1 hour. The pellet 
was re-suspended overnight at 4oC using either 0.1M sodium phosphate buffer 
or DI water to obtain the final VLP stock solutions for the device 
functionalization. 
 
Figure 2-6 TEM image of the purified VLP-FLAG (sample is diluted for imaging purposes). 
The purity and nanorod structure of the purified VLPs were verified 
using transmission electron microscopy (TEM), shown in Figure 2-6. It can be 






cell structures without major impurities in the purification process. The length 
of the VLP nanorods varies from around 50 nm to over 500 nm which is 
attributed to the lack of limitation from an RNA strand compared with TMVs. 
The successful purification of VLPs from bacterial growing media has 
established the foundation for the following self-assembly of these 
nanostructured sensing probes in transducers in a controlled manner.  
 2.4 VLP surface assembly process 
2.4.1 VLP self-assembly 
The VLP self-assembly on different materials was studied. These 
materials include gold, silicon oxide which is commonly used for electrode or 
insulating materials in microfabricated devices.  
In the experiments, 0.2 mg/mL of cysteine-expressed VLPs were used as 
the VLP sample. The assembly of VLP was performed by immersion of the 
substrate chips in the VLP sample solution at 25oC for 18 hours. The samples 
were visualized using scanning electron microscopy (SEM). For a better 
visualization, the metallization of surface self-assembled VLP was performed 
by 5 hours of palladium activation and a following 4 minutes of electroless 
plating of nickel. The metallization preserves the surface morphology of VLPs 
and forms a conductive nickel shell on the organic VLP nanorod surface, which 
lowers the charging effects during SEM imaging and improves the contrast 







Figure 2-7 SEM images of interdigitated electrodes after VLP-FLAG assembly in deionized 
water. 
The assembly of VLPs with binding peptide modifications (VLP-FLAG) 
was similarly studied on devices with gold and silicon oxide materials. As is 
shown in Figure 2-7, the VLP-FLAG self-assembled on both gold and SiO2. 
The density of VLPs is higher on gold because of stronger interaction between 
the –SH group on cysteine residue and gold. Also, the overall assembly density 
of the VLP-FLAG on gold is lower than VLP-1cys. This may be attributed to 
the presence of the bulkier 8 amino acid FLAG-tag peptide sequence which 
potentially blocks some cysteine residues from interacting with the gold surface.   
From the self-assembly experiments and SEM imaging, it can be 
confirmed that the cysteine residues on VLPs facilitated self-assembly on 
multiple kind of materials. This enables the use of VLPs as immobilized 
functional materials in a wide range of microfabricated sensors. On the other 
hand, there remain challenges such as long duration of the self-assembly 








in the presence of binding peptides. Therefore, there is a need for an improved 
self-assembly method and process to precisely control the formation of VLP 
functional layer. 
2.4.2 Evaporation-enhanced VLP assembly process 
 
Figure 2-8 VLP assembly processes with or without evaporation. 
Though the capability of VLP self-assembly on multiple materials has 
been validated, it is necessary to develop an enhanced VLP self-assembly 
method to minimize the amount of time and VLPs required functionalizing the 
sensor surface. Evaporation was studied as a means to achieve localized VLP 
assembly on chip using a much smaller amount of VLP stock solution. Figure 
2-8 illustrates the process of the evaporation-enhanced VLP assembly on-chip. 
In this method, a droplet of VLP solution with the volume of less than 50 µL 
(instead of bulk VLP stock solution) is applied on the 1 cm2 gold chip surface 
using a micropipette. By evaporating the VLP droplet in open environment for 
less than 1 hour, the VLPs can assemble on the gold surface due to self-
assembly and van der Waals force in evaporation. The evaporation-assisted 
process is aimed at great improvement in the VLP localization as well as 






Figure 2-9 (a) Optical image of (left) VLPs assembled electrode by immersion for 18 hours and 
(right) VLPs assembled on electrode by evaporation of 50 µL of VLP solution at room 
temperature for 1 hour. (b) SEM image of the VLP assembled in 18 hours. SEM image of (c) the 
center and (d) edge of electrode that functionalized by evaporation of VLP droplet. 
A VLP assembly test was carried out to determine whether immersion of 
a chip in VLP solution and evaporation of a VLP droplet on a chip surface 
yield significant differences in assembly morphology. From the optical image 
(Figure 2-9a), the electrode on the left (immersed in VLP solution) and the 
center area (where the 50 µL droplet of VLPs was located) of the electrode on 
the right showed the same dark colour. In the marginal region of the latter 
electrode the colour is light grey, meaning fewer VLPs were assembled there. 
Since electroless Ni plating was utilized to enhance the image contrast in SEM, 
the VLPs assembled on the marginal region is likely because of migration of 
non-specifically bound VLPs during the electroless Ni plating. The SEM 
images confirmed the density of VLPs assembled in Figure 2-9b and Figure 
2-9c were similar while it was lower in Figure 2-9d. It indicates that, using 





electrode while ensuring a good coverage, (2) the VLP assembly time can be 
significantly reduced and (3) localized VLP functionalization becomes possible. 
 
Figure 2-10 VLP morphology on the boundary of “coffee ring”. 
Due to higher surface tension, a thicker layer of VLP is formed on the 
edge of the VLP droplet on gold forming a “coffee ring”. In the SEM image 
(Figure 2-10), VLP assembled on gold showed a clear boundary that is purely 
confined by surface tension and evaporation of VLP solution.  
To advance the understanding of evaporation-enhanced assembly, the 
morphology, self-assembly time and peptide functionality of VLPs were 
studied with varying evaporation temperature during the assembly process. 
Table 2-1 lists the time corresponding to evaporation of 50 µL VLP solution on 
a 1 cm2 gold substrate. As the temperature increased from 30oC to 60 oC, the 
total time for evaporation was decreased by 87%. During the assembly process, 





Table 2-1 Evaporation time of 50µL of VLP-1cys solution on gold surface (ambient: temperature 
23°C, relative humidity 10%). 
Chip temperature Evaporation time 
30°C 45 min 
40°C 30 min 
50°C 15 min 
60°C 6.5 min 
 
 
Figure 2-11 Morphology of metalized VLP-1cys assembled at 30°C, 40°C, 50°C, 60°C. 
The evaporated VLPs were successfully metallized by Pd activation and 
Ni electroless plating, indicating that the cysteine residues on the VLP surface 







VLPs are observed for all conditions. At lower temperatures, the VLPs keep 
their nanorod structure and show uniform coating, but with a lower assembly 
density. At higher temperature, the VLPs become closely packed at the expense 
of less uniformity. When the temperature reaches 60°C, the shape of the VLPs 
moreover changes from “rod” to “disk”-like, losing the high-aspect-ratio 
feature. The high temperature may weaken the affinity between CPs causing 
the VLP nanorods to dissemble.  
2.4.3 Morphology of VLPs assembled through evaporation 
In our previous work, VLP assembly was previously performed in a 
stationary bulk solution overnight. The VLP nanorods in this process have not 
experienced high surface tension due to immersion in a relatively large volume 
of stationary solution. The VLPs suspended in the bulk solution are therefore 
assembled vertically, owing to the attachment of cysteine at the end of the VLP 
nanorod to the material surface. However, this well-observed phenomenon does 
not translate identically when evaporation is introduced in the VLP assembly 






Figure 2-12 SEM image of VLP assembled on a flat silicon surface using evaporation-assisted 
process 
SEM was utilized to study the influence of surface tension in the 
evaporation-assisted assembly on the morphology assembled VLPs. The SEM 
image in Figure 2-12 shows the VLPs attach horizontally onto the substrate. 
This parallel arrangement of VLP differs from the vertical VLP arrangement 
observed from VLP self-assembly process. Silicon is usually not a favourable 
surface for VLP assembly since –SH groups cannot form covalent bond with 
silicon. However, interestingly, the van der Waals force during the VLP 
solution evaporation “pulled” the VLP nanorods onto the silicon surface and 
forced relatively strong non-specific binding on the silicon. The VLP structures 
survived several washing steps and even the electroless Ni plating processes 
(for SEM imaging purposes).  
Therefore, the surface tension is one of the important factors to 
determine the morphology of TMV-assembled surfaces. When surface 





arranged VLP layer rather than a layer with vertically aligned VLPs. This 
brings the high density peptide receptors on VLPs much closer to the surface. 
When designing the transducers, the thickness of the VLP layer should be 
specially considered to achieve better sensitivity. 
2.5 VLP biosensing efficacy in immunoassays 
 
Figure 2-13 ELISA on gold chips with VLP evaporated at different temperatures.  
ELISA was performed on the gold chips functionalized by VLP using 
the evaporation-assisted assembly process. The functionality of the VLP-FLAG 
as sensing probes in ELISA was independently validated by colorimetric 
experiments conducted in parallel with the impedimetric sensing experiments.  
Dark-purple colored precipitates due to the interaction between substrate and 
enzymes on the secondary antibodies were observed on gold chips which have 
VLPs assembled through evaporation. The pictures of the gold chips after the 
full ELISA process are shown in Figure 2-13. It is clear that the dark-purple 
color of the precipitate is much more uniform in the center of the chip where a 
lower evaporation temperature was utilized. At a higher evaporation 
temperature, there was still the colored precipitate from biological binding; 
however, the uniformity of the precipitate degraded significantly.  Therefore, 
even though evaporation at a higher temperature can accelerated the process 
significantly, the process at a relatively low temperature can result in a much 
uniform VLP layer while keeping better biosensing efficacy of the binding 





peptides on the VLP surface. Overall, by evaporating the VLP-containing 
solution on the gold surface, the assembly of VLPs can be significantly 
accelerated and the localization can be greatly improved. This method also 
keeps good biosensing efficacy of the peptide receptor sequence on the VLP 
coat proteins.  
Appropriate evaporation temperatures need to be used to shorten the 
assembly time while keeping the integrity of VLP nanorods and the 
functionality of the peptides. Combining the results demonstrated in Figure 
2-11 and Figure 2-13, the upper limit of the VLP evaporation temperature is 
estimated at 50°C. However, the VLP shows better structural integrity and 
receptor functionality from room temperature to 30oC. Under these conditions, 
the evaporation of VLPs is a feasible means to rapidly assemble these 
genetically modified macromolecules and create a localized functional layer in 
a device.	
2.6 Chapter summary 
This chapter studied the TMV VLP molecular structure, genetic 
modification, surface attachment, and bioreceptor affinity and stability. 
Through genetic engineering, E. coli bacterial cells are able produce VLP coat 
proteins and that form VLP nanorod structures inside the cell. Genetic 
modifications have been made on the C- and N-terminal ends of each VLP coat 
protein. On the C-terminal end, a TNT binding peptide or a FLAG-tag peptide 
have been successfully expressed and confer the VLP highly selective chemical 





expressed which enables self-assembly of VLP nanorods onto a variety of 
material surface without chemical treatment. The surface morphology of the 
assembled VLP can be controlled by the surface tension in different assembly 
processes. Under high surface tension during the assembly process, the VLP 
nanorods closely attached parallel to substrate and aligned according to the 
flow direction. This morphology is different from the self-assembly in bulk 
solution where the VLPs attached vertically on the surface. Further study using 
colorimetric ELISA showed good biosensing efficacy of the VLP receptors. 
Experiments also showed that VLPs are stable at a wide range of evaporation 
temperature, and the evaporation of VLP on a substrate can promote the VLP 
localization.  
The fundamental study of the VLP sensing receptor genetic modification, 
preparation and characteristics provided important guidance to the later sensor 
design and system integration of VLPs. It also indicated that VLP is a versatile 






Chapter 3: VLP-based chemical explosive sensor 
Sensing of trace amounts of small toxic compounds such as explosive 
chemicals in complex aqueous environments faces significant challenges, 
including low signal level from the target molecules, large background signal 
as well as the requirement for ultra-sensitive transduction systems suitable for 
operation in solution. Conventional approaches are based on immobilization of 
receptors such as polymers, peptides, or antibodies on the transducer surface 
where the target species attach or react. The generated signal can be measured 
using fluorescent tags or in a label-free manner, as has been shown with field-
effect transistors [158-162]. While these sensors are selective, they require 
sophisticated microfabrication processes with high precision, surface 
functionalization steps before the measurements, or additional labelling after 
the binding event, limiting their potential use in practical applications.  
In this work, an alternative approach for sensing of small molecules that 
is based on VLP receptors as binding agents in solution is demonstrated. TNT 
is selected as a model target molecule to demonstrate the efficacy of this 
method, which can be readily expanded to other molecules with large contrast 
in size compared to the binding agents.   
Dr. Konstantinos Gerasopoulos and Dr. Xiao Zhu Fan contributed to the 
discussion of the diffusion modulation-based TNT sensing methods and 
provided help in the experiment. Dr. Hadar Ben-Yoav contributed to the 





3.1 TNT electrochemical sensing  
TNT is a widely used explosive and also a toxic chemical for organisms 
from bacteria to humans [163, 164]. The growing production and usage of TNT 
has resulted in contamination of soil and water in construction sites and 
weapon test grounds. When operating in solution, pulse voltammetric 
electrochemical sensors have been reported as the most sensitive approach to 
quantify TNT concentration, by analysing the peak current fingerprints from 
the electrochemical reduction of nitro groups (-NO2) to amine groups (-NH2) 
[165]. This method is not limited by the size of the analyte since it is based on 
charge transfer. However, selectivity is a bottleneck as the reduction peaks are 
very wide, and background subtraction is usually required to distinguish the 
TNT signal.  
  
Figure 3-1 (a) Three characteristic peaks of TNT obtained using square wave voltammetry, and 
(b) the correlation between the 1st peak currents at -0.53V and TNT concentration [166]. 
(Reprinted with permission from F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, 
and R. Ghodssi, Chemical Communications, 50, 12977, (2014). Copyright 2014, Royal Society of 
Chemistry) 
The sensing methodology employed here utilizes square wave 






signatures of TNT without VLP binding agents were first characterized using 
conventional square wave voltammetry where a 25 mV amplitude square wave 
was superimposed on a 4 mV step function at 50 Hz (Figure 3-1a). Three 
characteristic current peaks are observed in the voltage range from -0.3 V to -
0.9 V (vs. Ag/AgCl). Among these, the first peak at -0.53V arises directly from 
the reduction of the nitro groups in the TNT molecule, and was used for 
quantifying the TNT concentration. For reactions on planar electrodes, the net 
peak current ip can be expressed as, 
  
where the current is linear to the concentration c* and the square root of the 
diffusion coefficient D of TNT in the bulk solution [167]. TNT in acetonitrile 
was introduced in an electrolyte containing 5 mL of 0.1 M NaCl and 0.01 M 
sodium phosphate. The TNT concentration was varied from 0 to 20 µg/mL, and 
the relationship between current and concentration was verified to be linear 
(Figure 3-1b). However, this conventional TNT electrochemical sensing 
method still has not rule out the possible electrochemical current overlapping 
from the interfering chemical species in real-world applications: it is hard for a 
sensor to tell whether a current peak is contributed purely by TNT reduction or 
comprehensively by all the species at the same reduction potential. Therefore, 
an enhanced electrochemical method is necessary to improve the selectivity in 
the electrochemical sensing of TNT. 
1/2 *





3.2 VLP-based diffusion modulation method 
The VLP-based TNT electrochemical sensing method breaks the 
selectivity limitation by combining the fast response and high sensitivity of 
conventional electrochemical sensors with the selectivity of VLP bioreceptors. 
A unique feature of this sensing method is the use of modified Tobacco mosaic 
virus (TMV)-like particles (VLP) as free-floating binding agents in the bulk 
sample solution that modulate the target TNT diffusion coefficient during 
sensing. This allows selective TNT detection within minutes without the need 
for surface functionalization of the transducer, a typically time-consuming 
added step. This “TNT filtering” enabled by the biological binding agents is 
quantified by a differential current measurement method, where the reduction 
currents with and without VLP are measured. The specificity of the 
bioreceptors and the simplicity of use make the sensor suitable for TNT 
detection in complex aqueous environments in a rapid and selective manner. 
The VLP binding agents are used in microfabricated electrochemical sensors to 
study the compatibility of this sensing mechanism with on-chip microsensors 






Figure 3-2 Diffusion modulations of TNT using VLP-TNT binding agents [166]. (Reprinted with 
permission from F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, 
Chemical Communications, 50, 12977, (2014). Copyright 2014, Royal Society of Chemistry) 
The integration of VLP binding agents in the TNT-containing solution 
changes the peak current by modulation of the effective diffusion coefficient, 
which is inversely proportional to the hydrodynamic radii of the molecules. 
VLP-TNT is a large macromolecule assembled from thousands of individual 
coat protein subunits (molecular weight ~17.5 kDa), which are significantly 
larger than free TNT (~227.3 Da). The hydrodynamic radius of TMV was 
previously reported to be approximately 42nm [168] while that of TNT is less 
than 0.4 nm. The suspended VLP binding agents bind free TNT molecules on 
the receptor peptides-displayed outer surfaces, and form “composite” 
macromolecules with extremely low diffusion coefficient (Figure 3-2). This 





D’eff, and generates a unique differential current (Δip∝(D eff) 1/2-(D’ eff) 1/2). In 
practice, the differential current is calculated from the peak current in the 
presence of VLP-TNT binding agents and a negative control (VLP-1cys, a 
construct without binding peptides) from two independent experiments in an 
identical experimental set-up. This method eliminates the need for obtaining 
environmental background from clean samples (without TNT contamination). 
The TNT concentration is now able to be quantified from the specific 
electrochemical current change caused by the VLP and TNT biological binding. 
Therefore, this method is extremely valuable for directly quantifying the TNT 
contamination level from samples obtained from unknown environments.  
3.3 VLP nanoreceptors for TNT detection 
 
Figure 3-3 (a) TEM image of purified VLPs, and (b) genetic protein structure of VLP-TNT. [166] 
(Reprinted with permission from F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, 
and R. Ghodssi, Chemical Communications, 50, 12977, (2014). Copyright 2014, Royal Society of 
Chemistry) 
Figure 3-3 shows the TEM image and the schematic of the VLP-TNT 
receptor used in TNT sensing. Here, a previously identified TNT binding 
peptide [156] is utilized to genetically modify the TMV coat protein for 





sequence has been shown to exhibit very high selectivity to TNT versus other 
competing molecules such as 2,4-dinitrotoluene, demonstrating its suitability 
for selective TNT sensing in a complex solution. The VLP coat protein gene 
was modified by PCR-based mutagenesis using a primer that augmented the 
gene with a bacterially optimized sequence coding for the 12-amino acid 2,4,6-
trinitrotoluene (TNT) binding peptide WHWQRPLMPVSI at the C-terminus. 
The augmented coat protein gene did not produce full-length rods when 
subcloned into the pET21a bacterial vector and expressed in the BL21(DE3) 
bacterial expression system, possibly due to steric hindrance between adjacent 
coat proteins. To compensate for this, an amber stop codon was introduced 
between the 3’ end of the VLP coat protein gene and the coding sequence for 
the TNT binding peptide. This construct was subcloned into the pET21a 
expression vector and transformed into the JM109(DE3) bacterial expression 
system, containing the supE44 gene, which produces a tRNA that competes 
with the terminal TAG amber stop codon, allowing random read-throughs of 
the full, augmented coat protein. This produced a mixture of unaugmented and 
augmented coat proteins that self-assemble into nanorod structured VLP-TNT 
agents [166]. 
 















The asterisks indicate stop codons. 
3.4 Experimental results 
 
Figure 3-5 Chronoamperometry of 20 µg/mL TNT solution in the presence or absence of VLP-
TNT binding agents. [166] (Reprinted with permission from F. Zang, K. Gerasopoulos, X. Z. Fan, 
A. D. Brown, J. N. Culver, and R. Ghodssi, Chemical Communications, 50, 12977, (2014). 
Copyright 2014, Royal Society of Chemistry)  
The change of diffusion coefficient due to VLP and TNT biological 
binding was studied using chronoamperometry, where the current response was 
measured when applying a step potential from 0.2V to -0.6V (Figure 3-5). 





initial charging effect. The results were analysed using the Cottrell equation, 
which correlates the Faradaic current iF, diffusion coefficient D and time t 
(ΔiF(t)∝(D/Δt)1/2). The diffusion coefficient is inversely proportional to the 
change of 1/iF2 over time. The calculated TNT diffusion coefficient in buffer 
was 5.70×10-6 cm2s-1, in good agreement with previously reported values 
(6.71×10-6 cm2s-1). The diffusion coefficient of 4.40×10-6 cm2s-1 for unmodified 
VLPs (VLP-1cys) was 4.04 times higher than that of VLP-TNT (1.09×10-6 
cm2s-1). This indicates a Faradaic current ratio of 2.01 between control 
experiments and the bioreceptor VLP-TNT at a 20 µg/mL TNT concentration.   
 
Figure 3-6 Dynamic responses of the peak current with sequential introduction of 10 µg/mL TNT 
and 0.2 mg/mL VLPs in solution. [166] (Reprinted with permission from F. Zang, K. 
Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Chemical Communications, 
50, 12977, (2014). Copyright 2014, Royal Society of Chemistry) 
The dynamics of VLP-TNT binding were studied by monitoring the 





solution (Figure 3-6). The current decrease for the VLP-TNT was significantly 
higher compared to the VLP-1cys. In both cases, the currents stabilized after 
three minutes post introduction of the biomolecules. The instability of the 
current level in the first 3 minutes is a combination of biological binding and 
fluidic turbulence. Therefore, in later experiments, the TNT peak current was 
measured after 3 minutes of stabilization from the introduction of VLPs. 
 
Figure 3-7 Normalized peak currents vs. VLP concentration obtained from the reduction of 
10µg/mL TNT in solution. [166] (Reprinted with permission from F. Zang, K. Gerasopoulos, X. 
Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Chemical Communications, 50, 12977, (2014). 
Copyright 2014, Royal Society of Chemistry) 
The effective diffusion coefficient of the electroactive molecules was 
controlled by the ratio of bound and free-floating TNTs in solution. The TNT 
peak current in the presence of increasing concentration of VLPs is shown in 
Figure 3-7. The current decreases to 61.0% as concentration of the binding 





peak current is stable with only a 4.4% variation. The strong correlation 
between the current and binding agent concentration enables tunability of the 
proposed sensor by adjusting the sensitivity and resolution through the 
differential current. 
   
Figure 3-8 (a) Absolute peak currents and (b) differential currents of TNT reduction in the 
presence or absence of binding agents. [166] (Reprinted with permission from F. Zang, K. 
Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Chemical Communications, 
50, 12977, (2014). Copyright 2014, Royal Society of Chemistry) 
The response of the developed VLP-based sensor to increasing 
concentration of TNT was also studied. Due to TNT and VLP-TNT binding, 
the otherwise linear response of the current vs. TNT concentration that was 
observed in the negative control experiments (Figure 3-8a) is modified. The 
peak currents with VLP-TNT are subtracted from the peak currents of the 
control (Figure 3-8a), resulting in the differential peak currents (ΔIpeak) of 
Figure 3-8b. The differential current showed saturation when all the peptide 
binding sites on the VLPs were gradually occupied by TNT molecules.  When 
the concentration of binding agent increased from 0.2 mg/mL to 0.6 mg/mL, 






concentration. The slope of the differential current vs. TNT concentration 
increases with the concentration of binding agents, indicating an increase in 
sensor sensitivity. The Faradaic current ratio of VLP-1cys (0.6 mg/mL) to 
VLP-TNT (0.2 mg/mL) is 2.03. This matches well with the Faradaic current 
ratio calculated from the Cottrell equation in Figure 3-5, which validates that 
the nonlinearity in the current is due to the difference in diffusion coefficient 
between the two systems.  
    
Figure 3-9 (a) Optical image of on-chip electrochemical sensor, and (b) differential currents for 
varying concentrations of TNT. [166] (Reprinted with permission from F. Zang, K. Gerasopoulos, 
X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Chemical Communications, 50, 12977, 
(2014). Copyright 2014, Royal Society of Chemistry) 
Field applications outside laboratory settings require sensors that are 
portable and compatible with limited amount of reagents without 
compromising fast response and high selectivity. The feasibility of applying the 
VLP-based TNT sensing method in miniature sensors was investigated through 
the development and characterization of an on-chip electrochemical sensor. 
Gold working, counter and pseudo reference electrodes integrated with 30 µL 






forming a sensor array (Figure 3-9a). An interdigitated electrode geometry 
optimized in previous work [169] (50 µm finger width and spacing) was 
selected. The differential current between sensors in the presence of VLP-TNT 
and the control VLP-1cys was measured for varying concentrations of TNT 
(Figure 3-9b). As in the case of the experiments in bulk solution (Figure 3-8b), 
the differential current increases with TNT concentration. A clear saturation 
was not observed, suggesting that the linear region can be extended in a 
microscale sensor. These results demonstrate that the developed sensing 
method is applicable for microscale sensors for low-volume TNT detection. 
A differential sensing method using genetically modified 
macromolecules as binding agents for selective chemical sensing in aqueous 
environments was developed. The free-floating, suspended VLPs modulated 
the effective diffusion coefficient of the target TNTs within 3 minutes and 
contributed to unique differential current signatures that are proportional to 
TNT concentration. The genetically modified VLP bioreceptors were 
successfully tested in both beaker-scale and on-chip electrochemical sensors. 
This sensing method enables rapid label-free detection of TNT and can be 
expanded to a variety of electroactive species that have great size contrast with 
the programmable biologically engineered receptor macromolecules. 
3.5 Chapter summary 
This chapter focused on the development of VLP-based selective TNT 
sensor. The VLP binding agent is created by genetically modifying the VLP 





sequence on its outer surface. Electrochemical sensor was adopted to detect the 
TNT molecule in solution by quantifying its characteristic electrochemical 
reduction current peaks. The use of VLP binding agent improves the 
conventional TNT electrochemical sensing method and avoids the influence of 
interfering species and background. This improved method quantifies the TNT 
concentration by the measuring the effect of diffusion modulation in the 
selective binding of VLP binding agent and the target TNT molecules. The 
binding creates a much larger particle compared to the target TNT, 
significantly lowers the TNT diffusion coefficient in the system and generates a 
differential current. This differential current only relates to the presence of (1) 
target TNT molecule and (2) VLP binding agent.  
The method has been proved to be effective in both bulk sensor setups 
as well as in microfabricated sensor arrays. Therefore, the method is 
independent of any interfering species and environmental background signals, 
making it extremely desirable for directly quantify the TNT level in a blind 
sample. More importantly, this is a rapid method that does not need any sensor 
surface functionalization or VLP assembly process. With proper peptide 
modifications, the genetically modified VLPs are promising sensing probes or 







Chapter 4: VLP integration in impedance biosensor for antibody 
sensing 
 
Selective and sensitive detection of pathogens are crucial steps in 
identifying sources of disease outbreaks and forming effective strategies to 
ensure public health and food safety [53, 170]. Among the most effective and 
widely used biosensing methods nowadays are immunoassays, such as enzyme-
linked immunosorbent assays (ELISA), which are implemented to sense 
specific types of pathogens based on receptor-target interactions. This section 
explores and studies the feasibility of using self-assembled VLP layers on 
impedance microsensors as transduction layers.  
Dr. Konstantinos Gerasopoulos and Dr. Xiao Zhu Fan contributed to the 
discussion, and provided help in the VLP-FLAG purification in this work. 







Figure 4-1 Schematic of the impedance microsensor [157] (Reprinted with permission from F. 
Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Biosensors and 
Bioelectronics, 81, 401, (2016). Copyright 2016, Elsevier) 
Figure 4-1 shows a schematic of the impedance microsensor comprised 
of gold IDMEs, contact pads and a PDMS reaction chamber. In the fabrication 
process, a 500 nm thick SiO2 layer was fabricated using plasma enhanced 
chemical vapour deposition (PECVD) (Plasmalab System 100, Oxford 
Instruments) on a 500 µm thick silicon wafer. A 1.6 µm thick layer of Shipley 
1813 positive photoresist was spin-coated and patterned via photolithography 
to form contact pad and impedance sensor patterns. The exposed SiO2 area 
after the photolithography was isotropically wet-etched in buffered HF to form 
200 nm undercuts under the photoresist. Cr/Au (200Å/1400Å) layers were then 
deposited on a SiO2/Si substrate using e-beam evaporation (EXPLORER 14, 
Denton Vacuum), and were lifted off in acetone to pattern contact pads and 
IDMEs with 2 – 8 µm finger width and spacing. Compared with the 
conventional one-step lift-off process, this process creates a SiO2 barrier step 
between the neighbouring electrodes. Such barriers have been shown to provide 
higher sensitivity compared to coplanar electrodes [171]. Previously reported 
research has revealed that 95% of the effective electric fields and currents of 
IDMEs are concentrated above the electrode surface within a distance 
equivalent to an electrode spacing plus half of an electrode width [172]. Thus, 
in order to maintain high sensitivity in monitoring probe assembly and ELISA, 
the minimum width and spacing of the IDMEs were designed to be 2 µm, 





is 2 mm × 2 mm. The impedance sensors were cleaned with 10 minutes of O2 
plasma at 150 W to remove organic residues. A 3 mm-thick 
Polydimethylsiloxane (PDMS) with a 30 µL cavity was fabricated separately 
and attached to the sensor substrate as the reaction chamber. During VLP self-
assembly on the impedance sensor, as well as the on-chip ELISA experiments, 
an additional layer of PDMS is temporarily attached on the PDMS reaction 
chamber to seal the cavity, therefore, preventing the 30 µL liquid sample from 
rapid evaporation, and maintaining constant analyte concentration and ionic 
strength. The reaction chamber and cover layer were used throughout the VLP 
self-assembly on the impedance sensor as well as the on-chip ELISA 
experiments.  
Electrical impedance spectroscopy was performed using an 
electrochemical workstation (CHI660D, CH Instruments, TX). The excitation 
used a 50 mV amplitude of alternating current (AC) signal in the frequency 
range of 10 Hz – 1 MHz. Parallel experiments to monitor the impedance 
evolution on multiple microsensors were achieved by connecting the sensor 
electrodes to the CHI660D electrochemical workstation through a multiplexer 
(CHI684, CH Instruments, TX). The equivalent electrical circuit of the 
designed impedance microsensor while monitoring VLP self-assembly and 
immunoassays is shown in Figure 4-1. This circuit has been widely used for 
describing the biomedical impedance spectroscopy model in literature [173-
175]. In this model, Rc represents the parasitic and contact resistance between 





capacitive coupling between the IDMEs, Rs represents the solution resistance 
between the electrodes, and Cdl is the double layer capacitance on the 
electrode/electrolyte interface. During electrical impedance spectroscopy, the 
conduction current will propagate through Rs and the displacement current will 
propagate through Ccell; therefore, the Rs and Ccell components are connected in 
parallel. The solution resistance Rs is connected in series with the interfacial 
capacitance Cdl of the two electrodes. The interfacial capacitance Cdl 
contributes primarily to the total impedance of this equivalent circuit when the 
operating frequency is below Flow, where the total impedance Z, critical cut-off 
frequency Flow and interfacial capacitance Cdl can be expressed as, 
  (1) 
  (2) 
 (3) 
In equation 3, εr is the relative dielectric constant of the media directly 
in contact with the electrode surface and A is the area of the electrode that is 
directly in contact with the ionic solution. In the frequency range lower than 
Flow, the total impedance increases with decreasing frequency. The decrease in 
dielectric constant εr and effective electrode area A during biological molecule 
binding on the surface results in the reduction of Cdl value, which can also 






















4.2 Impedimetric ELISA procedure 
The VLP sensing probes (VLP-FLAG) are synthetized by the helical 
arrangement of thousands of genetically modified and identical TMV coat 
proteins inside Escherichia coli bacterial cells. Each coat protein produced 
expresses a cysteine residue that promotes surface attachment and a FLAG-tag 
sequence (DYKDDDDK) that enables selective binding with the target anti-
FLAG antibody. The genetic modification, culture and purification procedures 
were reported in detail previously [154]. The purified VLPs were diluted and 
suspended in deionized (DI) water at a concentration of 0.2 mg/mL. This VLP 
stock solution was used in the surface functionalization of the impedance 
sensors. 
After the VLP-FLAG sensing probes were self-assembled on the 
impedance sensor surface, on-chip ELISA was performed to validate the VLP 
probe efficacy in sensing the target anti-FLAG antibodies. Determining factors 
such as IDME geometries and VLP concentrations used in sensor 
functionalization were studied in order to achieve better sensing performance in 






Figure 4-2 Schematic of the procedure of sandwiched on-chip ELISA using VLP-FLAG [157] 
(Reprinted with permission from F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, 
and R. Ghodssi, Biosensors and Bioelectronics, 81, 401, (2016). Copyright 2016, Elsevier) 
Sandwiched ELISA (Figure 4-2) was used as a model system to 
investigate the sensing efficacy of assembled VLP-FLAG sensing probes to 
anti-FLAG antibody targets. In the process, VLP-FLAG sensing probes were 
introduced in the reaction chamber and self-assembled on the impedance sensor 
surface. After washing off excessive VLPs on the device using buffer solution, 
a Tris-buffered saline (TBS) (1X) solution containing 12 ng/mL – 1.2 µg/mL of 
target primary anti-FLAG IgG antibodies, produced from rabbit (dilution of 
F7425, Sigma-Aldrich) was introduced in the reaction chamber. A 1:10000 
dilution of Goat anti-Rabbit IgG (whole molecule)-Alkaline Phosphatase 
antibody (A3687, Sigma-Aldrich) was subsequently introduced in the reaction 
chamber. In the final step, the nitro-blue tetrazolium chloride and 5-bromo-4-
chloro-3'-indolyphosphate p-toluidine salt (NBT/BCIP) substrates (Fischer 
Scientific) were added into the chamber for interaction with the enzyme on the 
secondary antibody, producing dark-purple insoluble precipitates on the surface. 
Between all steps, the devices surfaces were washed 3 times using TBS and 
one time using TBS with 0.05% Polyoxyethylene (20) sorbitan monolaurate 
(Tween 20) buffer solutions. The impedance changes were continuously 





4.3 Experimental results 
4.3.1 VLP assembly on impedance sensor 
 
Figure 4-3 Scanning electron microscopy (SEM) images of the (a) top-down and (b) cross-
sectional views of self-assembled VLP layer on IDMEs. [157] (Reprinted with permission from F. 
Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Biosensors and 
Bioelectronics, 81, 401, (2016). Copyright 2016, Elsevier) 
Figure 4-3a shows the SEM image showing the impedance sensor 
surface after functionalization using 18-hour self-assembly of VLP-FLAG at a 
concentration of 0.2 mg/mL. Before SEM imaging, the surface was pre-treated 
with one hour palladium activation and 4 minutes nickel electroless plating to 
enhance the contrast in SEM. The nanorod shaped VLPs (white particles in 
Figure 4-3a) uniformly cover the impedance sensor surface, forming a 
functional layer. The cross-sectional SEM image (Figure 4-3b) shows that the 
VLPs are quasi-vertically aligned on the electrode surface due to the interaction 
between the sensor surface and exposed cysteines at the end of each VLP rod. 
The average length of each VLP is about 1 µm, and the maximum VLP layer 
thickness reaches around 3-4 µm due to stacking of VLPs. Impedance sensors 
with IDME features of 2 µm and 8 µm (two times the lengths of a single VLP 







Figure 4-4 Real-time impedance and mass loading measurement using the developed impedance 
microsensor. [157] (Reprinted with permission from F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. 
Brown, J. N. Culver, and R. Ghodssi, Biosensors and Bioelectronics, 81, 401, (2016). Copyright 
2016, Elsevier) 
The imaginary part of the complex electrical impedance on a sensor with 
8 µm electrode feature size, was measured to analyse the VLP self-assembly 
dynamics over an 18-hour duration. Figure 4-4 shows the impedance (red 
squares) changes detected by the designed impedance microsensor during VLP 
self-assembly. The impedance amplitude trends reflected the rapid attachment 
of VLP sensing probes to the surfaces in the initial 3 hours followed by a 
gradual increase of attachment throughout the 18 hours of self-assembly. These 
results show that the impedance sensors are capable of real-time monitoring of 
VLP sensing probe self-assembly on the transducer surfaces of a more compact 
platform. The impedance change reveals that the first 3 hours during VLP self-






4.3.2 Detection of antibodies using on-chip ELISA 
 
Figure 4-5  Percentage impedance change –Zim % (a) during VLP self-assembly and ELISA 
process, and (b) after ELISA process with different target primary antibody concentrations. The 
error represents the standard deviation of the mean (n=3) [157] (Reprinted with permission from 
F. Zang, K. Gerasopoulos, X. Z. Fan, A. D. Brown, J. N. Culver, and R. Ghodssi, Biosensors and 
Bioelectronics, 81, 401, (2016). Copyright 2016, Elsevier) 
Figure 4-5a shows the changes of the imaginary part of the electrical 
impedance observed using different IDMEs functionalized by VLPs at different 
concentrations. The impedance increases significantly during the VLP 
assembly process due to both the decrease in direct electrode/electrolyte 
interfacial area and the lower effective dielectric constant, as discussed 
previously in section 4.1. The slight decreases in the impedance during both 
antibody binding steps may be attributed to the disassociation of the non-
specifically bound VLPs on the sensor surface (through bonds other than thiol-
gold), and diffusion into the Tris-buffer during the testing. The sensor 
responses in the full ELISA also showed that the largest overall impedance 
shifts are from experiments using the IDMEs with 8 µm feature size and 0.6 





In order to understand the determinant factors influencing the sensing 
efficacy such as VLP concentrations and electrode geometric parameters, two-
way analysis of variance (ANOVA) is utilized to analyse the statistical 
significance of the data sets in Figure 6a. The ANOVA test shows that VLP 
concentration is the only major source of variation (F=15.72>Fcrit, 
p=0.0041<0.05) that controls the percentage impedance level after ELISA 
process. The test also shows that, regardless of electrode feature size, all 
impedance sensors response similarly as the VLP concentration increases. 
These analytical results indicate that VLP concentration is the dominant factor 
for the VLP-based impedance biosensor performance. A higher VLP 
concentration will contribute to enhanced impedance sensor responses in the 
immunoassay. 
Table 4-1 Percentage changes in capacitive impedance during sensor surface functionalization 













In VLP assembly 185% 231%  197% 242% 
In ELISA 21% 23%  22.62% 27% 
 
Table 4-1 summarizes the percentage impedance changes in the VLP 
assembly and the ELISA processes. In VLP assembly, the relative changes of 
impedance (imaginary part) amplitudes measured were compared between VLP 





imaginary impedance were compared between measurements after VLP self-
assembly (step 1 described in section 4.2) and after precipitate formation (step 
4 described in section 4.2). Both sensor designs show high sensitivity to VLP 
attachment on the surface, measuring up to about 240% increase in imaginary 
impedance using 8 µm IDMEs and 0.6 mg/mL VLP concentration. However, 
compared with the 8 µm feature size sensors, those with finer electrode features 
of 2 µm do not show higher impedance shifts during the ELISA process, and it 
showed less VLP-FLAG concentration dependency. This may be attributed to 
the saturation of the effective sensing area by the dense VLP layer, which 
degrades the sensor performance during the immunoassay. 
Figure 4-5b shows the total percentage of imaginary impedance 
amplitude change in the ELISA process when different concentrations of anti-
FLAG antibody were used. Sensors with 8 µm electrode width and spacing 
functionalized by 0.6 mg/mL VLP-FLAG sensing probes were used in this 
study. Tris-buffer solution with no anti-FLAG was introduced as the control in 
the ELISA. In the control experiment, the impedance change was 12% due to 
non-specific binding of secondary antibody and precipitate formation on the 
sensor. In the sensing experiments, the impedance sensors detected 19%, 28% 
and 36% of total impedance increases after the entire ELISA procedure when 
12 ng/mL, 120 ng/mL and 1200 ng/mL of target anti-FLAG primary antibody 
were used, respectively. The error bars in Figure 4-5b represent the standard 
deviation of the results from three independent experiments using newly 





(R2=0.997) between the percentage impedance change and antibody 
concentration (log scale), the sensitivity of the VLP functionalized microsensor 
can be calculated as 8.7% of the total impedance per magnitude of antibody 
concentration (ng/mL). The detection limit of target antibody for the on-chip 
impedimetric ELISA is 9.1 ng/mL.  
4.4 Chapter summary 
The study in this chapter explored the VLP as sensing probes in an 
affinity-based biosensor whose transduction mechanism relies on binding of 
target molecules onto immobilized sensing probes of a transducer. The 
transducers used in this study were impedance microsensors, which detected 
the complex electrical impedance shifts on the interdigitated electrode due to 
biological molecule binding. An antigen-antibody binding model system was 
utilized to evaluate the biosensing efficacy of the VLPs. Each VLP coat protein 
was genetically modified with an 8 amino acid-long FLAG-tag peptide and a 
cysteine residue. These modifications enabled selective binding with the target 
anti-FLAG IgG and promoted surface assembly on gold electrodes. 
The impedance sensor detected the complex electrical impedance 
changes on the electrode surface during biological binding. By real-time 
monitoring of the impedance at 100 Hz, the dynamics of VLP self-assembly 
was studied revealing the saturation on the surface in 3 hours. On-chip 
immunoassay process was performed on the VLP-functionalized impedance 
sensor in order to quantify the concentration of the target anti-FLAG IgG. The 





presence of 9.1 ng/mL targets using the full ELISA process. This work 
revealed VLP self-assembly dynamics and demonstrated the potential of VLPs 








Chapter 5: Microsystem solution for controlled and accelerated 
VLP integration and biosensing on-chip  
 
In this chapter, a microsystem solution is developed for accelerated VLP 
sensor functionalization and performance-enhanced VLP-based biosensing. 
Capillary microfluidic devices – capillary micropumps and stop valves – are 
utilized to achieve autonomous VLP assembly directly on impedance 
microsensor surface. With the dense VLP coverage, the impedance sensor is 
able to detect the presence of target antibody label-free. 
Dr. Konstantinos Gerasopoulos contributed to the discussion of the 
capillary microfluidic design and microfabrication. Mr. Adam D. Brown 
contributed to generating the model and purification protocol of the VLP-
FLAG receptors. 
5.1 Microsystem design 
The integrated sensing microsystem is composed of capillary 
microfluidics and an impedance sensor, aiming at autonomous liquid sample 
delivery, receptor localization, accelerated sensor functionalization, and real-
time label-free sensing of target molecules.  
The three main modules and their functions are: 
Sensing module: impedance sensing to monitor VLP sensing probe 
assembly and the target antibody binding on the VLP receptor layer. 
Control module: confining the VLP solution to the sensing module area 





Venting module: withdrawing the liquid from the sensing and control 
modules to wash unbound target molecules on impedance sensor 
The three main components of this LOC system are: 
Impedance sensor: the impedance between microscale interdigitated 
electrodes will be continuously monitored during the VLP self-assembly and 
target molecule binding processes. The impedance change will be used to 
evaluate the quality of the self-assembled VLP receptor layer and quantify the 
concentration of target molecules. 
Capillary microfluidics: capillary microfluidics created by micropillar 
structures using hydrophilic materials will be used to autonomously deliver the 
VLP and target molecules in the system. Capillary stop valves will be used in 
the control module to limit the VLP solution in the sensing area.  
 
Figure 5-1 Schematic of the capillary microfluidics and impedance sensor-integrated sensing 
microsystem. (a) The top-down view of the microsystem design showing three main modules: 





impedance sensor in the sensing module and (c) the details of the stop valve and triggering 
channel designs in the control module. 
Figure 5-1 shows the schematic of the integrated sensing microsystem. 
According to the different functions, the system components can be catalogued 
into three essential modules: sensing, control and venting. An impedance 
sensor and a capillary micropump comprise the sensing module. The 
impedance sensor spans a 4 mm × 4 mm area with interdigitated electrodes in 4 
µm width and spacing. The capillary micropump in the sensing module can 
autonomously deliver the VLP-containing solution onto the impedance sensor 
through capillary action. Owing to its large micropump area and open top 
surface, the micropump will rapidly evaporate the VLP-containing solution, 
and enhance the attachment of VLPs to the impedance sensor surface through 
both thiol-gold interactions and van der Waals forces. The control module 
contains capillary stop valves and a triggering micropump with the channel 
direction perpendicular to the sensing and venting micropumps. During the 
sensor functionalization with VLPs, the stop valves can confine the VLP 
solution to the left sensing module due to the local energy barrier induced by 
the sharp change in the sidewall geometry. During antibody sensing, a 
triggering fluid will be introduced from the triggering channel in the control 
module. This triggering fluid will mix with the test antibody sample and break 
the liquid/air interface at the stop valves, and will eventually induce continuous 
flow through the VLP functionalized impedance sensor. The large capillary 





keep the antibody test sample flowing during sensing. The detailed principle of 
operation of the sensing microsystem is included in the supplementary material. 
5.2 Capillary microfluidics sub-system 
The LOC sensor system is designed toward on-site sensing applications. 
The portability and the convenience in operation are important. To achieve this, 
the complex external tubing and pumping setups for conventional microfluidics 
need to be eliminated. Here, autonomous open-channel capillary microfluidics 
is proposed to accomplish VLP sample delivery in the self-assembly process as 
well as the transfer of test samples to the active sensing area in the LOC system. 
The liquid in the reservoir will be automatically driven into microfluidic 
channels due to one-directional capillary force.  
As shown in Figure 5-1c, the two major types of capillary microfluidic 
components are capillary pumps and capillary stop valves, which are 
responsible for generating autonomous flow in the channels and limit the liquid 
passively in certain areas, respectively. In the following sections, the detailed 
analysis on the capillary force generation and stop valve design will be 
discussed. 
5.2.1 Capillary microfluidic channel design and simulation 
The calculation of the designed open channel capillary microfluidics is 
based on the following model: 
With XY as the substrate plan, the open microfluidic channel is created 





are w and d, respectively. The meniscus of the flow advances along the +X 
direction (Figure 5-2). Gravity and the initial transit phenomena when the flows 
first enter the channel are neglected.  
 
Figure 5-2 3D schematic of the open microcapillary with the definition of parameters 
The capillary force is due to the change of interface free energy E along 
the microfluidic channel experienced by the moving fluidic meniscus. Figure 
5-3 shows the analysis of the interface free energy changes that are considered 
in the calculation. A is the interface area, γ is surface tension.  E1 is the surface 
energy between liquid/air interfaces on the top of the microfluidic channel. As 
the meniscus of flow advances in the channel, the initial solid/air interfaces on 
the substrate and sidewall are changed to solid/liquid interfaces. The changing 
energy ΔE in this process equals to the sum of E2 and E3 on the substrate and 






Figure 5-3 Cross-sectional schematic of the microcapillary with free interfacial energy 
definitions 
The surface tensions between the interfaces of solid, liquid and air can 
be correlated using Young’s equation, which is expressed as 
0cos substrateel_substrates_substrattesl_substra =+− θγγγ                                          (1) 
Where, θsubstrate is the contact angle of substrate (defined in Figure 5-4). 
 
Figure 5-4 Contact angle and the surface tensions of a drop of liquid on solid substrate 
Therefore, the change of free energy can be rewritten as, 
msidewalll_sidewalllsl_sidewalsubstrateel_substrattesl_substrael_substratel_substrat coscos EAAAE +⋅−⋅−⋅=Δ θγθγγ
 





In which, the w and d are width and depth of microfluidic channel. The 
p is the microfluidic channel aspect ratio equalling to d/w. 














EF    (3) 
To ensure the liquid can automatically flow in the capillary 
microfluidics, the capillary force expressed in equation (3) needs to be positive. 
Using Matlab simulation, the influence of aspect ratio (channel 
depth/width (p)), sidewall contact angle, and substrate contact angle on the 
capillary force can be evaluated. 
Aspect ratio (microfluidic channel depth/width) 
 
Figure 5-5 Capillary forces vs. the aspect ratio (depth/width) of the microfluidic channel 
At constant contact angles of the sidewall and substrate material, the 
capillary forces can be calculated with respect to the change of aspect ratio 
























(depth/width, p in the equation). From Figure 5-5, the capillary force is 
decreased to 0 at the aspect ratio of 0.236 (depth/width). The force shows a 
dramatic increase when the aspect ratio increases from 0 to 1. Therefore, the 
microfluidic channels on the chip need to maintain an aspect ratio of greater 
than 0.236 to ensure one way flow. The capillary force then gradually reaches a 
saturated level as the aspect ratio increases further beyond 2~3. It can be 
concluded that a higher aspect ratio will result in a larger capillary force to 
keep the advancing of flow. And the aspect ratio of around 2 to 3 is optimized 
considering the difficulty in fabricating high-aspect-ratio structures using 
photolithography on the KMPR photoresist.   
Sidewall contact angle 
To study the effect of sidewall contact angle on the capillary force, SiO2 
(contact angle: 50o) is used as substrate material in the calculation. Water is 
used as liquid sample. Two aspect ratios of microfluidic channel (depth/width), 






Figure 5-6 Capillary force vs. the contact angle of sidewall material with different aspect ratios 
From the results in Figure 5-6, capillary force is positive if the contact 
angle of microfluidic sidewall θl_sidewall is lower than 80o for aspect ratio of 1. If 
the aspect ratio is increased to 2, capillary force can be positive for contact 
angle lower than 85o  
Substrate contact angle 
Use 1:1 aspect ratio for microfluidic channel geometry and O2 plasma 
treated KMPR as sidewall material (fixed contact angle θl_sidewall=40o), the 
relation of capillary force and substrate material contact angle is studied. 































Figure 5-7 Capillary force vs. the contact angle of substrate material with different aspect ratios 
When the contact angle of substrate is larger than 123o, the capillary 
force is around 0 for aspect ratio of 1. If the aspect ratio increases to 2, the 
capillary force will always be positive no matter what the contact angle is for 
the substrate (Figure 5-7). 
The Matlab simulation results indicated that aspect ratio and sidewall 
contact angle are the two most important factors that determine the capillary 
force in a capillary microfluidic device. The sidewall need to be higher than 
0.236 and the sidewall contact angle should be smaller than ~80o to ensure a 
positive capillary force as the driving force. Therefore, achieving a higher 
aspect ratio around 2-3 and selecting more hydrophilic sidewall material are 
favourable for device function. 





























5.2.2 Calculation of capillary valve design 
The capillary stop valve is a passive valve that operates based on 
localized low surface energy created by a rough change in channel-flow 
direction angle (β in Figure 5-8). In Figure 5-8, the curvature of liquid front is 
defined by angle α which is related with the surface tension. Assuming the 
contact angle of the substrate and sidewall to be similar θl_sidewall ≈θl_substrate = θc 
=40°. 
 
Figure 5-8 Angle definition: top-down view of microfluidic capillary stop valve 
As shown in Figure 5-9, at the critical point, the capillary pressure 
should be 0, which means the meniscus is a flat surface (α=0°). The 
equilibrium angle between liquid and solid will be π-θc= π/2+ βc. Therefore, 






Figure 5-9 Capillary stop valve design at critical point of “zero” capillary force 
For the hydrophilic surface material with a contact angle of 40°, the 
change of angle β ≥ βc = 90°-θc=90°-40°=50° in order to change the capillary 
pressure from positive to zero.  
5.3 Principle of operation 
A test sequence of the proposed LOC system includes (a) VLP localized 





5.3.1 VLP localized self-assembly 
 
Figure 5-10 Schematic of VLP assembly in LOC system 
As shown in Figure 5-10, during the VLP assembly process, the VLP 
suspended in DI water is introduced from the sample reservoir and limited in 
the sensing module because of the capillary stop valves. The VLP solution 
evaporates at room temperature. Impedance sensor will monitor the impedance 
change to evaluate the assembly process of VLP through the change in the 





5.3.2 Target molecule binding 
 
Figure 5-11 Schematic of fluidic triggering before antibody sensing 
The buffer solution is first introduced in the device to establish baseline 
impedance after VLP assembly. After the impedance measurement, a triggering 
fluid is applied in the control module to trigger the venting of the liquid from 
the sensing to the venting module (Figure 5-11). Then, the buffer solution that 
contains target antibody will be introduced to the left sample reservoir and 
enter the sensing area. The impedance change during the antigen-antibody 





5.3.3 Real-time antibody sensing 
 
Figure 5-12 Schematic of impedance measurement in continuous flow 
 
Once the impedance in step (b) stabilizes, buffer solution will be 
introduced again to wash off all the unbound residues in sensing area. The 
electrical impedance at this stage will be measured and compared with the 
initial value before the introduction of target molecules (Figure 5-12). 






Figure 5-13  Microfabrication process flow of the microfluidics integrated impedimetric sensing 
microsystem: (a) patterning of photoresist, (b) e-beam deposition of Cr/Au, (c) lift-off of 
photoresist to create interdigitated impedance sensor electrodes, and etching of SiO2 in BOE, 
and (d) creating capillary microfluidic layer through patterning of KMPR 
The fabrication process flow of the microsystem is demonstrated in 
Figure 5-13. A 500 µm-thick silicon wafer with a 200 nm-thick SiO2 
passivation layer deposited using Plasma Enhanced Chemical Vapour 
Deposition (PECVD) was utilized as the substrate. Negative photoresist NR9-
1500PY (Futurrex Inc., NJ, USA) was spin-coated at 3000 RPM for 30 seconds 
to form a 1.5 µm-thick photoresist layer. The photoresist was patterned using 
photolithography with an exposure energy dose of 280 mJ/cm2 at 365 nm 
wavelength (Figure 5-13a). After development, Cr/Au (20 nm/140 nm) was 
coated on the patterned wafer using NEXDEP E-beam Deposition (Angstrom 
Engineering, Ontario, Canada) (Figure 5-13b). The metals deposited on the 
photoresist were then removed in a lift-off process in acetone, creating the 
impedance sensor features on the wafer. A 45-second buffered HF etch was 
performed to expose the silicon (Figure 5-13c), a more hydrophobic substrate 
material. The driving capillary force is mainly provided by the changing 
interfacial energy on the sidewall, which largely depends on the sidewall 
geometries. After impedance sensor fabrication, KMPR 1050 (MicroChem 
Corp., MA, USA) was spin-coated at 3000 rpm for 30 seconds, to form a 60 
µm-thick layer. The KMPR was soft-baked at 100 oC for 20 minutes before 
exposure at a dose of 1000 mJ/cm2 at 365 nm with UV light. The wafer was 





completed in SU-8 developer for 4 minutes followed by rinsing in isopropyl 
alcohol (Figure 5-13d).  
After fabrication, the integrated sensing microsystem was exposed to O2 
plasma (50 W, 0.5 Torr) for 5 minutes in order to remove residues in the 
microfabrication process as well as render the KMPR microfluidic layer 
hydrophilic[176, 177].  










For impedance sensor functionalization, 5 µL of 0.1 M sodium 
phosphate buffer solution containing VLPs at concentrations of 0.2 mg/mL, 2 
mg/mL or 4 mg/mL were pipetted in the sample inlet shown in Figure 2. Due to 
capillary action, the VLP solution was automatically distributed on the 
impedance sensor surface (Figure 5-14a). The VLP concentration above the 
impedance sensor increased as the solution evaporated, promoting high-density 
assembly of VLPs on the sensor through both thiol-gold binding and van der 
Waals forces (Figure 5-14b).  
In the subsequent antibody sensing, the sensor was rinsed twice with 5 
µL of 1X Tris-buffered saline (TBS) solution to remove non-specifically 
attached VLPs from the sensor surface. Then, the target anti-FLAG antibodies 
with increasing concentration from 10 ng/mL to 10 µg/mL in 5 µL 1X Tris 
buffer were added from the sample inlet. 1 µL of 1X Tris buffer was introduced 
from the triggering channel after the antibody-containing buffer solution filled 
the entire sensing module, which broke the barrier of the stop-valves and 
induced continuous flow of test samples from the sensing to the venting 
module (Figure 5c). The electrical impedance on the sensor was measured in 
real-time during both VLP sensor functionalization and target antibody binding. 
Specifically, an AC signal at 100 Hz with amplitude of 50 mV was applied 
between the IDT electrodes using a VSP-300 potentiostat (Bio-Logic Science 
Instruments SAS, France) to analyze the VLP assembly dynamics and quantify 





5.6 Characterization of the capillary microfluidics operation 
 
Figure 5-15 SEM image of the microfabricated sensing microsystem. The SEM image shows (a) 
the overview of the integrated sensing microsystem containing sensing, control and venting 
module, (b) the interdigitated electrodes of the impedance sensor in the sensing module, and (c) 
the capillary stop valve in the control module 
The surface morphology of the microfabricated sensing system was 
characterized using scanning electron microscopy (SEM) and optical 
interferometry. Figure 5-15a is the SEM image showing the fabricated capillary 
stop valves, and the micropumps in the sensing and triggering modules. The 
KMPR 1050 negative photoresist shows high-aspect-ratio pillar structures with 
smooth sidewalls. KMPR micropillars show good adhesion on the impedance 





liquid meniscus-sidewall angle to more than 150o, forming sharp nozzle shapes 
and a localized free energy barrier (Figure 5-15c). Optical profilometry was 
utilized to further inspect the geometric dimensions of the microfluidic layer.  
The geometric dimensions, such as depth and width of the developed 
capillary system, were measured using WYKO NT 1100 optical profilometer 
(Veeco Instruments Inc., AZ, USA). The depth of each channel in the capillary 
micropump is measured as 60 µm (Figure 5-16), while the width is 25 µm, 
resulting in an aspect ratio (channel depth/width) of 2.4. At the stop valves, 
aiming at an increased controllability of sidewall geometry to the liquid 
meniscus advancing, the width of the channel is reduced to 15 µm, resulting in 
an aspect ratio of 4. This enhanced aspect ratio improves the isolation of liquid 
using the stop valves.  
 
Figure 5-16 Optical profile of the microfluidic system 
A 5-minute O2 plasma treatment was performed on the KMPR 





(contact angle of 6o). Long-term stability test also showed the water contact 
angle on the O2 plasma treated KMPR stabilized at around 40o after two 
months of storage, still more than sufficient to achieve a positive capillary force 
(Figure 5-17). 
 
Figure 5-17 KMPR Contact angles before and after O2 plasma activation at 50W for 5 minutes 
The flow regulation function of the stop valves before triggering, and 
the flow distribution in the system after the triggering of stop valves, were 
characterized using optical interferometry. A 5 µL water sample containing 
polystyrene microbeads of 10 µm diameter were loaded from the sample inlet. 
These microbeads were confined in the sensing module due to the presence of 
capillary stop valves. The movements of the microbeads due to the initial 
filling in the channel and the Brownian motion distorted the water/air interface, 
creating a different reflection patterns compared with water. The trajectories of 
these microbeads were recorded using vertical scanning interferometry through 
the optical profilometer operating at a low scan rate of 1 µm/s (Figure 7). It can 
be clearly seen that the microbeads suspended in DI water were confined only 





and venting modules unfilled. This scenario is analogous to when VLP-
containing solution was introduced during the sensor functionalization process. 
 
 
Figure 5-18 (a) Liquid sample filling in the sensing module before triggering of stop valves. (b) 
Trajectories of microbeads in the capillary microfluidic sub-system after stop valves triggering 
Optical profilometry image in Figure 5-18a shows that the microbeads 
suspended in DI water were confined only in the sensing modules on the left of 
the stop valves, leaving both triggering and venting modules unfilled. This 
reflects the circumstances present when the VLP-containing solution is 
introduced during the sensor functionalization process. Figure 5-18b 
demonstrates the distribution of flow in the microsystem after triggering of the 







evenly through the sensing module on the left side and left an evenly 
distributed trajectory pattern of the microbeads. This even distribution will 
enable the delivery of target molecules on the full area of the sensor, thus 
maximize the use of assembled VLPs toward sensitive antibody detection.  
Figure 5-19 demonstrates the distribution of flow in the sensing 
microsystem after triggering of the stop valves. The white parts in this 
grayscale image represent the trajectories of the microbeads traveling within 
the microfluidics. These suggest that, after triggering of the stop valves, the 
liquid samples could flow evenly through the sensing module. This maximizes 
the effective impedance sensing area and contributes to a more sensitive 
impedance sensor for quantifying antibody binding. The flow distribution in the 
sensing and venting modules were further quantified and compared using the 
image analysis program – ImageJ [178, 179]. 
 
Figure 5-19 Grayscale optical profilometry image of trajectories of microbeads flowing in 
the capillary microfluidic device after triggering the stop valves 
As is shown in Table 5-1, the percentage deviation of the flow 





to large capillary force and changes in the channel width from large to small, 
the particles have a larger probability of flowing into the channels on the side 
of the nozzle. This results in a 46.78% deviation in the greyscale level on the 
trajectory plot. This analysis validated that the current design can ensure an 
even distribution in the sensing area in the antibody sensing stage, which 
ensured the maximum usage of the effective impedance sensor electrode area 
on-chip. 
Table 5-1 Grayscale levels in “Area A” in the sensing module and “Area B” in the venting 
module in Figure 5-19 







221.25 7.76 3.5% 
Area B 
(Venting) 
143.67 66.97 46.78% 
5.7 Experimental results 
5.7.1 VLP assembly in capillary microfluidics 
A 5 µL drop of 0.1 M sodium phosphate buffer solution containing 
VLP-FLAG nanoreceptors was introduced in the inlet of the capillary 
microfluidics. The concentration of VLPs in the solution was varied from 0.2 
mg/mL (a previously characterized minimum concentration to ensure coating 
uniformity) up to 4 mg/mL (the highest concentration achieved after 
purification). The VLP-containing solution was delivered autonomously in the 





constraints from the stop-valve array. The stationary VLP solution in the 
sensing area completely evaporated within 15 minutes at room temperature.     
 
Figure 5-20 SEM images of the VLP-FLAG functional nanoreceptor layer assembled through 
autonomous delivery and enhanced evaporation in the open-channel capillary microfluidics. The 
morphology of VLP nanoreceptors assembled using (a) 0.2 mg/mL VLP-FLAG in 0.1M 
phosphate buffer, where the enlarged view (b) shows the VLP nanorod assembled in parallel 
with the impedance sensor surface, forming a flat arrangement of nanoreceptors, and the 
morphology of VLP nanoreceptors assembled (c) 4 mg/mL VLP-FLAG in 0.1M phosphate 
buffer, where the enlarged view (d) shows the VLP nanorods forms clusters and piled-up on the 
impedance sensor electrode due to van der Waals force or electrostatic interactions  
The surface morphology of the VLP nanoreceptor assembled through 
evaporation in the capillary microfluidic device was studied using scanning 
electron microscopy (SEM). Palladium activation and electroless nickel coating 
were performed on the VLP-assembled device to enhance the SEM imaging 
contrast. Figure 8a shows the uniform coating of VLP-FLAG nanoreceptors on 





channel using 0.2 mg/mL VLPs in the buffer solution. Both the impedance 
sensor and microfluidics retained their original profiles. The enlarged view in 
Figure 8b shows flat and dense attachment of VLP-FLAG nanoreceptors on the 
IDT electrode surface, forming a thin VLP functional layer. When the 
concentration of VLPs was increased to 4 mg/mL, the VLPs form clusters due 
to the non-specific binding caused by van der Waals forces and electrostatic 
interactions (Figure 8c). These clusters of VLP nanoreceptors increase the total 
volume of VLPs available in the sensor system; however, a closer view of the 
VLP morphology on the electrode also shows that the high concentration VLPs 
result in the aggregation of these nanoreceptors with random orientation 
(Figure 8b). Overall, with both low and high VLP concentrations, the density of 
the assembled VLPs on the impedance sensor through evaporation in the open 
capillary microfluidics is much higher compared to that previously achieved in 
a closed chamber.  
The cross-sectional SEM images of the VLP-assembled sensor electrode 
(Figure 5-21) show distinct difference in the VLP layer when difference VLP 
concentrations are utilized in the assembly process. A low VLP concentration 
(0.2 mg/mL) resulted in a low thickness of 0.53 µm. And, a higher VLP 
concentration (4 mg/mL) in the assembly process formed a thicker VLP 
stacking up to 1.78 µm (a 3-fold increase compared to that achieved using a 






Figure 5-21 Cross-sectional SEM images of the VLP-assembled sensor electrode. The VLP 
concentrations used in the assembly were (a) 0.2 mg/mL and (b) 4 mg/mL. 
5.7.2 Label-free antibody sensing 
The electrical impedance between the interdigitated electrodes was 
measured every 10 seconds during both VLP assembly on-chip and antibody 
sensing. The percentage impedance change (imaginary part of the complex 
impedance) at 100 Hz was utilized to analyse the VLP and antibody 





permittivity of 4-13) attach to the electrode surface, they will displace water 
(relative permittivity of ~80) on the electrode/liquid interface. This will lower 
the effective dielectric constant on the electrode surface, and will reduce the 
area (and thus the associated capacitance capacitance) of the ionic double layer 
defined by the electrode/electrolyte interface. Therefore, an increase in the 









Figure 5-22 (a) Real-time percentage changes in the impedance (amplitude of imaginary part) 
between IDT electrodes during VLP assembly. (b) Percentage impedance changes when 
antibodies were introduced to the VLP-functionalized impedance sensors. Complimentary 
receptors and targets – VLP-FLAG and anti-FLAG IgG – were utilized in the sensing 
experiments. In the two control experiments, non-specific receptors (VLP-1cys at 0.2 mg/mL) or 
non-specific target antibodies (anti-rabbit IgG) were used. Experiments with the same conditions 
have been repeated independently on multiple sensors (n=3). The error bars represent the 
standard deviations  
Figure 9a shows the evolution of the relative impedance during the 
assembly of VLP on the sensor’s IDT electrodes. It is shown that, using the 
open capillary microfluidic device as delivery platform, the impedance between 
the IDT electrodes increased by more than 120% and saturated within 6 
minutes after introducing a drop of 0.2 mg/mL VLP-FLAG nanoreceptors. In 
contrast during the control experiment, the impedance changed less than 2% 
when only buffer solution was delivered. In previous work that utilized VLP 
self-assembly, the VLP could saturate the electrode surfaces in 3 hours. The 
accelerated VLP assembly process using the capillary microfluidic system may 






more solution is drawn in via the capillary pump. These results show not only 
the capability of using impedance sensors in studying the dynamics of 
nanoreceptor assembly on sensors, but the great advantage of using open-
channel capillary microfluidics to accelerate the assembly process through 
enhanced evaporation as well.  
After the accelerated VLP assembly, the VLP-functionalized impedance 
sensor was utilized to perform label-free antibody sensing. The binding of 
target anti-FLAG antibodies with concentrations ranging from 10 ng/mL to 100 
µg/mL in the 1X TBS buffer were studied. The increasing antibody 
concentrations were sequentially applied onto the VLP-functionalized 
impedance sensors surfaces. The sensors were functionalized using 0.2 mg/mL, 
2 mg/mL or 4 mg/mL of VLPs in order to reveal the optimized sensor 
conditions for a better sensitivity. 
Figure 9b shows the resulting percentage change in imaginary 
impedance of the VLP-functionalized sensors. Impedance shifts from non-
specific bindings were studied in two control experiments. In the first control 
experiment, non-specific VLP-1cys at 0.2 mg/mL concentration were used to 
functionalize the sensors, which generated the impedance changes of less than 
7.8% at the maximum anti-FLAG concentration of 100 µg/mL. In the second 
control experiment, the 0.2 mg/mL VLP-FLAG functionalized sensors 
responded to non-specific binding anti-rabbit IgG with the maximum of 5.7% 





On the other hand, the impedance sensors functionalized using VLP-
FLAGs at various concentrations all showed significantly larger impedance 
increases. This indicates that VLP-FLAG is a highly selective biosensing probe 
with respect to the target antibody. Interestingly, when the impedance sensor 
was functionalized using the lowest concentration of VLP-FLAG (0.2 mg/mL), 
the highest sensitivity during antibody binding was observed. At the maximum 
target antibody concentration of 100 µg/mL, the impedance sensor 
functionalized using 0.2 mg/mL VLP-FLAG showed an impedance increase of 
29.6% while the one functionalized using 4 mg/mL VLP-FLAG only showed 
an increase of 21.2%. This substantial difference in the sensor performance 
may be a result of the significant difference in the VLP morphology achieved 
by using different VLP concentrations during assembly. Though the amount of 
VLPs attached on the sensor is considerably larger using a higher VLP 
concentration, it also decreased the porosity of the VLP layer, thus losing the 
surface area. Also, a higher VLP concentration also leads to a larger thickness 
of the VLP layer, which kept the subsequently attached antibodies away from 
the electrode surface, thereby decreasing the sensor sensitivity. Using a lower 
VLP concentration, the VLPs assembled as a closely packed flat monolayer on 
the electrode surface, allowing the attached antibodies to directly impact the 
double layer capacitance, thus increasing the sensitivity of the system. 
Therefore, among all the tested VLP concentrations, the 0.2 mg/mL is the 
optimized sensor functionalization condition to achieve a better antibody 





From the sensing experiments in Figure 9b, the maximum sensitivity of 
the sensors is 4.12% impedance change per log10(ng/mL) antibody 
concentration. The resolution of the VLP functionalized sensors was calculated 
to be 3.9% impedance change (3 times the standard deviation when measuring 
buffer solution). Therefore, the detection limit of the VLP-FLAG 
functionalized sensor is 8.84 ng/mL (equivalent to 55 pM anti-FLAG IgG). The 
results showed great potential of using VLP-functionalized impedance sensors 
to perform rapid label-free biosensing in the real-time. 
5.7.3 System regeneration 
 
Figure 5-23 Surface regeneration using DI water and NaOH treatments at room temperature 
and 90oC 
NaOH is a commonly used base for cleaning organic compounds in 
experiments or life. The positive photoresist developer contains about 0.6% 
NaOH to remove the cross-linked photoresist. In the experiments, both DI 
water and 2% NaOH were compared at both room temperature and 90oC in 
terms of their VLP removal efficacy. Figure 5-23 shows the optical 





devices at different temperature. From the images, the 2% NaOH treated gold 
chip and microfluidic device both show good surface cleaning efficacy, 
removing the black-colored VLP layer from the surfaces. 
 
Figure 5-24 SEM images showing the morphology of the metalized VLP-coated surfaces with or 
without cleaning procedure in different chemicals and conditions. (a) No cleaning, (b) 2% NaOH 
cleaning at room temperature, (c) DI water cleaning at 90oC, (d) 2% NaOH cleaning at 90oC 
Figure 5-24 shows the SEM images of the device surfaces after the 
aforementioned different surface treatment. The VLP coated gold chips have 
gone through four different surface treatments: (a) no cleaning, (b) cleaning 
using 2% NaOH at room temperature, (c) cleaning using DI water at 90oC, and 
(d) cleaning using 2% NaOH at 90oC. The aim is to find the best procedure to 
remove the VLPs without affecting the properties of the device. As the control 
experiment, the VLPs assembled firmly on both bare gold surfaces if no 
cleaning procedure is performed, which formed the VLP nanorod forest on the 





solution before metallization, only scattered distribution of VLP subunits can 
be observed (Figure 5-24b). When the temperature of the chips were elevated 
up to 90oC, both DI water and NaOH treated surface lost the original VLP rod 
structures (Figure 5-24c and Figure 5-24d); however, the DI water treated 
surface still have a much larger quantity of VLP subunit attached on the gold 
surface compared with NaOH treated one. The better surface regeneration 
efficacy using NaOH may owe to the denaturisation of VLP coat proteins after 
exposing to high pH-level base solution. 
 
Figure 5-25 Impedance responses in VLP assembly before and after sensor regeneration 
Figure 5-25 shows the detailed impedance responses of the VLP 
assembly on a new sensor surface (red solid curve) and on a sensor surface that 
was regenerated using 2% NaOH at room temperature (black dashed curve). 
The VLP assembly shows much faster saturation on the regenerated sensor 





removal of VLPs on the sensor surface. On the other hand, the overall 
impedance responses are similar between the two devices, and the impedance 
of the sensor after VLP functionalization is comparable between the two 
devices. This indicates that the sensor can be functionalized with VLPs again 
after cleaning the surface, but the quality of VLP assembly on the sensor may 
not be completely the same as the new one. 
 
Figure 5-26 Impedance responses to increasing target anti-FLAG concentration on a sensor 
before and after surface regeneration 
The VLP assembly and sensing efficacy of the sensor microsystem after 
surface regeneration were validated. The impedance responses from the same 
sensor before and after surface regeneration were compared in Figure 5-26. 
With either new sensor or regenerated sensor, the impedance responses were 
very similar to the increasing target antibody concentration from 10 ng/mL to 1 





new sensor showed more stable and continuous impedance increase compared 
with the regenerated sensor. As the antibody concentration further increased to 
1 µg/mL, the new sensor showed higher impedance change of 15% compared 
with lower than 10% from the reused sensor. The impedance fluctuation in the 
regenerated sensor may attribute to the detachment of VLPs on the surface due 
to degraded VLP binding strength on the surface. The new sensor also showed 
slight larger relative impedance increase compared with the regenerated one. 
Though there are differences in the sensor characteristics due to the 
regeneration, the VLP-functionalized regenerated sensor can still be utilized to 
perform label-free antibody sensing and quantify the concentration of the target 
molecule. Therefore, the VLP-based impedance sensor is reusable and 
reconfigurable in the integrated capillary microfluidic system.  
5.8 Chapter summary 
Based on the fundamental understanding of VLP material characteristics 
and the self-assembly limitation in sensors, a microsystem comprising capillary 
microfluidics and impedance microsensors is developed to further enable 
accelerated VLP assembly and rapid biosensing. The open channel capillary 
microfluidic components include capillary micropumps and stop valves, aiming 
at controlled and accelerated assembly of VLP receptors on impedance sensor 
surface. The capillary micropumps autonomously deliver the VLP-containing 
solution into the sensor microsystem due to capillary driving forces in the 
microfluidic channel surface. The evaporation of the VLP solution from the 





minutes, a significant reduction of time compared to the existing 3-18 hours of 
VLP self-assembly process. Owing to the dense VLP receptor assembled 
closely on the impedance sensor electrode surface, the sensor is able perform 
label-free antibody sensing within 5 minutes after sensor functionalization, and 
is able to achieve a detection limit of 55 pM of target anti-FLAG IgG. This 
microsystem platform greatly enhanced the VLP assembly process in the aspect 
of time, density and morphology. It is also an integrated sensor microsystem 
that is capable of controlled sensor functionalization and rapid target molecule 
quantification for on-demand biosensing applications. This is also the first time 











Chapter 6: Summary 
6.1 Summary 
A systematic study has been performed to establish the integration of the 
macromolecule – Tobacco mosaic virus virus-like particle (TMV VLP) – as 
selective receptor in electrochemical microsensor systems in both chemical and 
biological sensing applications. This work explored the genetic modification 
methods, purification procedure and material properties of the VLP sensing 
receptors. Based on a thorough understanding of the VLP characteristics, the 
VLPs were integrated in electrochemical sensors for TNT explosive sensing, 
and in impedimetric sensors for antibody sensing through immunoassay 
process (ELISA).  The capabilities of VLPs as universal and versatile receptor-
displaying vehicles for the integration into sensors with different transduction 
principles, and for the detection of targets with different scales have been 
validated through experiments. A microsystem platform with capillary 
microfluidics and impedance sensors was further developed to leverage the 
self-assembly capability and biological affinity of VLPs. The system achieved 
controlled, accelerated VLP sensor functionalization and sensitivity-enhanced 
antibody sensing (Figure 6-1). Overall, this work combined the fundamental 
research of the material properties of an emerging biological receptor, the 
development of bio-nano-receptor integration methodology, and the 







Figure 6-1 Schematic of the capillary microfluidic system with integrated impedance sensor for 
rapid VLP assembly and label-free sensing 
The TMV VLP molecular structure, genetic modification, surface 
attachment onto substrates, and biological binding efficacy and stability were 
first studied. By the multiple genetic modifications of the TMV coat proteins 
produced in the E. coli bacteria hosts, thousands of identical coat proteins were 
able to be self-assembled into nano-rod structures with genetically engineered 
binding affinity on the outer surfaces of the nanorods. The two different 
constructs of VLPs with either a TNT binding peptide or a FLAG-tag peptide 
on each of the coat protein C-terminal end were successfully developed. With 
the cysteine residue on the TMV coat protein N-terminal end, all the TMV 
VLP constructs can be self-assembled on to a variety of material surfaces 
without chemical treatment. The morphology of a VLP-assembled surface can 
be controlled by VLP concentration, flow and evaporation conditions (Figure 





colorimetric ELISA. The genetically modified VLPs showed good stability in a 
wide temperature and pH ranges.  
 
Figure 6-2 Schematic of the evaporation-based VLP assembly process 
The genetically modified VLPs were utilized as sensing elements in 
both miniaturized chemical and biological sensors for TNT chemical explosive 
and antibody sensing. The TNT sensor operated based on the diffusion 
modulation from the TNT and receptor VLP binding which selectively changed 
the TNT electrochemical characteristics in a voltammetric microsensors. Due 
to the distinct size difference between the VLP-TNT binding agent and target 
TNT molecule, binding of TNT onto the VLP binding agent can greatly lower 
its diffusion coefficient, selectively inducing a quantifiable decrease in the TNT 
characteristic redox current peak. By comparing with the control experiment, 
the differential current was utilized to quantify the concentration of the target 
TNT molecules. This method leveraged the high TNT binding affinity of the 
genetically modified VLPs and added selectivity to the traditional 





the presence of both target TNT and binding agent VLP, the clean 
environmental sample and background signal analysis are no longer necessary, 
making the VLP-based TNT sensor suitable for direct sample analysis.  
The integration of VLPs as receptors in biological sensors for medical 
applications was also studied. The VLP receptors carrying FLAG-tag peptides 
on the coat proteins were integrated in impedance microsensors for antibody 
sensing. The VLPs assembled onto interdigitated electrode surfaces through 
self-assembly, formed a functional nano-receptor layer on the impedance 
sensor surface. The real-time impedance evolution during the VLP assembly 
process revealed the VLP self-assembly dynamics, which indicated the 
saturation on the surface within 3 hours. The subsequent sandwiched 
immunoassays validated the efficacy of the assembled VLPs as selective 
receptors in the impedance sensor. The VLP-FLAG assembled impedance 
sensor was able to quantify the concentration of the target anti-FLAG IgG 
using immunoassay on-chip. Meanwhile, by increasing VLP concentration 







Figure 6-3 SEM image of microfabricated open-channel capillary microfluidics for rapid VLP 
assembly and biosensing 
Based on the fundamental understanding of VLP material characteristics 
and the self-assembly limitation in sensors, a microsystem comprising capillary 
microfluidics and impedance microsensors was developed to further enable 
accelerated VLP assembly and rapid biosensing. The open channel capillary 
microfluidic components included capillary micropumps and stop valves were 
developed for controlled and accelerated assembly of VLP receptors on 
impedance sensor surface (Figure 6-3). The capillary micropumps 
autonomously delivered the VLP-containing solution into the sensor 
microsystem using capillary driving forces in the microfluidic channel surface. 
Evaporation of the VLP solution from the capillary micropump surface resulted 
in an accelerated VLP assembly within 6 minutes, a significant reduction in 
time compared to the existing 3-18 hours of VLP self-assembly process. Owing 
to the dense VLP receptor assembled closely on the impedance sensor electrode 






minutes after sensor functionalization, and achieved a detection limit of 55 pM 
for anti-FLAG IgG sensing. This microsystem platform greatly enhanced the 
VLP assembly process in terms of time, density and morphology. It was also an 
integrated sensor microsystem capable of controlled sensor functionalization 
and rapid target molecule quantification for on-demand biosensing applications. 
This is the first time that capillary microfluidics is utilized for enhanced sensor 
functionalization.  
6.2 Future work 
Based on the fundamental understanding of TMV VLP characteristics 
and its biosensing capabilities, the potential future directions of the VLP-based 
sensing research include multiplexed sensing, multi-functional VLP sensing 
probes assembly, and three-dimensional (3D) VLP-based sensor architecture 
for improved sensitivity. 






Figure 6-4 Schematic showing the multiplexed VLP-based sensor platform concept enabled by 
microfluidics 
The joint operation of passive capillary micropumps and stop valves has 
demonstrated the possibility of controlling the VLP assembly location in a 
microsensor. This provides chances to sequentially pattern multiple kinds of 
VLP constructs genetically modified with different receptor peptides on 
separate sensors and form a sensor array. After the sensor array 
functionalization, the test sample that containing mixed analytes in solution can 
flow through the sensor array. By monitoring the impedance changes from each 
sensor, the composition of the test sample can be analysed. Thus, multiplexed 
sensing can be achieved that reduces the time and cost for biological sample 
analysis.  
Alternatively, different VLP constructs can also be delivered 
simultaneously onto single impedance microsensor by multiple capillary 
micropumps. If these VLP constructs all express cysteine residues on their coat 
protein and are suspended at the same concentration, the evaporation-based 
VLP assembly will create a “composite” VLP functional layer on an impedance 
microsensor surface, enabling multiplexed biosensing affinity. Compared to the 
aforementioned method, this alternative method can reduce the cost of 
microelectrode fabrication and lower the variations from VLP assembly quality 
on different sensors. 
Two VLP constructs have been demonstrated as bioreceptors in 
chemical and biological sensing model systems. These model systems can be 





characteristics or dielectric constants. In the next step, more real-life 
application-relevant VLP receptors will be genetically engineered, and aimed at 
molecules such as cancer biomarkers, cardiac biomarkers and toxins.  
Multi-functional VLP receptor assembled from sub-units:  
Rather than creating multiple sensors, a different route to achieve the 
multiplexed sensing is creating multi-target sensing receptor or probe on the 
molecular level. Working toward this goal requires the assembly of a single 
VLP from sub-units carrying different receptor peptide on the sub-units’ coat 
proteins. Preliminary experimental results have shown that the assembly of 
multi-functional VLP rods can be realized by programmed complimentary 
affinity between coat proteins and the pH response of VLPs. 
 
Figure 6-5 VLP receptors with multi-target sensing sub-units 
The first step toward this goal is to further study the controllability of 
VLP assembly and disassembly using pH levels in the solution. Microfluidics 
provides unique opportunities to efficiently study the pH responses from VLP. 
For example, two capillary microfluidic pumps can deliver VLP-containing 
buffer solutions at two extreme pH levels, pH=3 and pH=9, to the same area 
on-chip. Once the two fluids mix in the center, a natural pH gradient will form 





be efficiently studied. Very importantly, the VLPs assembled at different pH 
condition should hold geometric integrity once the environment is restored to 
neural pH=7, a usual condition in which most biomarkers are tested. 
The next step is to validate that VLPs assembled in different pH level 
can maintain similar biosensing efficacy. This step is extremely critical because 
part of the affinity of a binding peptide to its target molecule is due to charge 
preference. Florescence or colorimetric ELISA can be utilized in this validation. 
Three-dimensional VLP-coated sensor electrodes:  
In the current research, the impedance sensor electrodes use a planar 
setup which is compatible with the conventional photolithography process. 
However, the efficiency for target molecule capturing is not optimized: a large 
amount of target molecules flow through the bulk microfluidic channel without 
effectively touching the VLP-functionalized electrodes on the substrate. To 
further increase the target molecule capture efficacy, it is necessary to create 
three dimensional sensor electrodes, and microfluidic channel with similar 






Figure 6-6 SEM image showing TMV 3D coating on gold-coated silicon pillars. [180] (Reprinted 
with permission from S. Chu, K. Gerasopoulos, and R. Ghodssi, Journal of Physics: Conference 
Series, 2015, p. 012046. Copyright 2015, IOP Publishing Ltd.) 
In the future work, possible three-dimensional sensor electrodes can be 
fabricated using the emerging 3D printing process. This can further improve 
the surface area and optimized the utilization of the limited footprint of a 
microsensor resulting in an enhanced sensitivity. A resin-based interdigitated 
3D structure can be printed on the substrate. By metal deposition with a 
shadow mask, the 3D structures can be metalized into interdigitated electrodes 
for impedance sensing. Also, interdigitated electrodes may not be the ideal 
feature in 3D to achieve the highest surface area. A parallel study can be done 
to investigate the most efficient electrode geometric for the largest surface-to-
volume ratio. This will result in improved VLP coating for sensitivity 
biosensing. 
6.3 Conclusion 
Chemical hazards and biological pathogens are threatening our lives in 
both public and personal levels. Rapid, selective and sensitive detection of 
these invisible pathogenic molecules are crucial for tailing the control and 
treatment strategies. This dissertation addressed these needs through the 
integration of Tobacco mosaic virus-like particles (VLP) macromolecular 
receptors in miniaturized biosensors. These genetically modified and 
nanostructured receptors greatly enhanced both the selectivity and sensitivity of 
chemical and biological microsensors. The VLP-based explosive 





mechanism, which was able to quantify the concentration of the target TNT 
molecules in solution without being influenced by interfering species. The 
integration of VLPs in impedance microsensors through both self-assembly and 
evaporation-enhanced assembly processes have created affinity-based 
biosensors for antibody detection. The highly integrated sensor microsystem 
comprising VLP receptors, capillary microfluidics and impedance sensor 
showed experimental results of rapid sensor functionalization, label-free 
sensing, programmability and portability; thus, it is a promising microsystem 
for on-demand and on-site biological sensing. The fundamental research of 
VLP assembly protocols and the rapid system-level solution for VLP 
integration in sensors provided foundations for developing next generation 






Appendix I – Matlab codes for capillary force calculation 
Calculating the relations between capillary force and contact angle of microfluidic 
sidewall (with a constant substrate contact angle of 50o). 
d=60*10^-6; % channel depth 60 micron 
p1=1;% 1/aspect ratio=1 
p=0.25;% 1/aspect ratio=2 















xlabel('Contact angle \theta of sidewall (deg)'); 
ylabel('Capillary force (N)'); 
legend('Aspect ratio (depth/width)=0.5','Aspect ratio 
(depth/width)=1','Aspect ratio (depth/width)=2'); 
Calculating the relations between capillary force and contact angle of substrate (with 
a constant sidewall contact angle of 40o). 
d=60*10^-6; % channel depth 60 micron 
p=0.5;% aspect ratio=2 













xlabel('Contact angle \theta of substrate (deg)'); 
ylabel('Capillary force (N)'); 






Calculating the relations between capillary force and microfluidic channel aspect 
ratio. 
d=60*10^-6; 










xlabel('Channel aspect ratio (depth/width)'); 
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